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ABSTRACT

Author: To, Celina Z. M.S.
Institution: Purdue University
Degree Received: May 2018
Title: A 3D Cell-Based Assay to Detect Shiga-Like Toxin Producing Escherichia coli
Major Professor: Arun Bhunia
Shiga-like toxin producing Escherichia coli (STEC), a foodborne pathogen, poses a serious
public health risk. Rapid detection of STEC in the food supply remains to be a challenge because
current detection methods lack the ability to differentiate viable and non-viable STEC or active
and inactive Shiga-like toxins (Stx) in less than 24 h.

Here, our goal was to develop a

mammalian cell-based assay (CARD) for rapid high-throughput detection of Shiga-toxin
producing Escherichia coli using Vero (monkey kidney epithelial cells) or THP-1 (human
monocyte cell) cell lines. Initially, optimal mammalian cell concentration needed to show a
maximum cytotoxicity towards a membrane active detergent, Triton-X 100 (2%) or crude Stx
was determined by using different dilutions of Vero cells (8 ×103 – 2.6 ×105/well). Cytotoxicity
was assayed by measuring the lactate dehydrogenase (LDH) release in a spectrophotometer and
by Trypan blue uptake in a light microscope. Then, the effect of STEC growth media (Luria
Bertani (LB) broth, modified tryptic soy broth (mTSB), or E. coli (EC) broth), and antibiotics
(mitomycin C, 2 μg/ml, ciprofloxacin, 100 ng/ml, and polymyxin B, 1 mg/ml) on assay
interference using Vero and THP-1 were examined. Stx production after UV and antibiotic
treatments were quantified by dot-immunoblot using anti-Stx antibodies. Next, both cell lines
were grown and immobilized in a collagen gel matrix to create a 3-dimension (3D) platform,
CARD, which was further evaluated to determine the limit of detection (LOD), and optimal time
(2 – 16 h) required to obtain a positive response against crude or purified toxin preparations.
Finally, the CARD was tested for specificity against a panel of pathogenic and commensal
bacteria in a buffer or in a model food system, where 27 raw ground beef samples (32 ± 3.2 g)
were inoculated at 4 CFU/g. Bacterial isolates in food were further verified by stx1 and stx2specific multiplex PCR and by plating on selective agar media, sorbitol MacConkey agar
(SMAC). Optimal mammalian seeding cell number was determined to be 3.2 × 104 cells/well,
which showed maximum cytotoxicity after exposure to a STEC O157:H7 strain 204P for 16 h.

xvi
LB mixed with Dulbecco’s modified Eagles’ Medium (DMEM) showed the least interference
with Vero cell cytotoxicity than mTSB or EC broth. Likewise, mitomycin C and ciprofloxacin
had no negative effect on Vero cells while polymyxin B did. Ciprofloxacin induced 1.2-fold Stx1
production while mitomycin C induced a 3.2-fold Stx2 production, compared to the polymyxin B
and UV light induction. Analysis of cytotoxicity of viable STEC cells on 3D Vero gave the
highest LDH release as opposed to Vero and THP-1 cells in their natural monolayer or
suspension state, referred to as 2D, and the LOD was estimated to be 107-8 CFU/ml or 31.25 ng
toxin/ml in 6 h with a cut off value of 12-15% i.e., three standard deviations above the mean of
all negative controls. Crude or purified Stx preparations showed low but similar cytotoxicity
towards both cell lines either in 2D or 3D configuration, but at 16 h, toxins induced the highest
cytotoxicity from 3D Vero than the 2D Vero, 2D THP-1, or 3D THP-1. STEC or toxin-induced
Vero/THP-1 cell damages were also confirmed by Trypan blue staining and Cryo-SEM. 3DCARD was highly specific for STEC cells and did not yield any positive response from
Salmonella enterica, Listeria monocytogenes, Citrobacter freundii, Hafnia alvei, Serratia
marcescens, and non-pathogenic E. coli. Finally, 3D-CARD successfully detected STEC from
artificially contaminated ground beef samples (n=27) following a 15-h enrichment (~108 CFU/ml)
in mTSB and 6-h cytotoxicity assay, with confirmation of STEC from positive food samples on
SMAC plate and stx1 and stx2 specific PCR. This study investigated and compared the
cytotoxicity of STEC or cell-free Stx preparation on THP-1 and Vero cell line in 2D and 3D
platforms and the study is the first of a kind for such analysis. The results demonstrated that 3D
Vero cell-based CARD is suitable for detection of STEC or Stx after a 15-h enrichment in mTSB
followed by a 6-h cytotoxicity assay providing results much faster than the traditional Vero cell
assay that requires 72 h or longer.
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LITERATURE REVIEW

1.1

Escherichia coli

Escherichia coli (E. coli) is a Gram-negative rod-shaped bacterium that belongs to the
Enterobacteriaceae family (Farrokh et al. 2013). Members from this family are typically nonpathogenic, but can become opportunistic and cause infections when host becomes
immunocompromised. There are also strains that are pathogenic, which is the causative agent for
gastrointestinal or diarrheal illnesses. The difference in virulence attributes between pathogenic
E. coli and a non-pathogenic E. coli, such as the K-12 strain, is shown in Figure 1.1 (Kuhnert et
al. 1995). Intestinal pathogenic E. coli can be further divided into six pathotypes,
enterohemorrhagic or Shiga-like toxin producing E. coli (EHEC), a subgroup of Shiga toxinproducing E. coli (STEC), enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC),
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent E. coli
(DAEC), where STEC is usually the bacterium that poses the highest number of outbreaks that
threatens public health (Pihkala et al. 2012). Pathotypes are then classified into serotypes based
on surface structures such as the O and flagella or H antigen. The typical serotypes that produces
toxins are O157 and the big six, O26, O111, O103, O121, O45 and O145, which live in the
intestinal tract of animals or in contaminated soil and surface waters. STEC comprises of more
than 200 serotypes and of those 200 serotypes, most do not cause illnesses because it does not
contain the LEE pathogenicity island. Under severe cases, infection can progress and lead to
hemolytic uremic syndrome (HUS).
Most serotypes can survive at low pHs (~4.4) with minimum water activity of 0.95 and
are able to grow at temperatures from 7 to 50ºC (WHO 2017). When temperature reaches 70ºC
or higher, STEC can be destroyed via food processing. Its ability to not only survive in acidic
and chilled foods, but also to grow in vast temperature ranges is a major reason that these
products must be monitored closely for any STEC growth. Treatments that normally destroy
STEC cells in processed food may not be appropriate for raw food such as ground beef, spinach
and bean sprouts. In this case, there is a challenge in the food industry in controlling the presence
of STEC in raw food.

2
Foodborne infections and illnesses associated with EHEC results in hemolytic colitis (HC)
and in some cases a severe disease called hemolytic uremic syndrome (HUS) (Rangel et al.,
2005). EHEC is responsible for approximately 265,000 cases of foodborne illnesses each year
(CDC 2012b). Although it has a low mortality rate of 0.8%, it is still a serious illness with a high
rate of hospitalization affecting children, the elderly, and immunocompromised individuals
accounting for a high percentage of fatality and complications (Karmali et al. 2010; CDC 2012b;
Sperandio and Nguyen 2012). EHEC infected patients will usually experience nausea, vomiting,
abdominal cramps, diarrhea, and dehydration, which can last from one to sixteen days depending
on the lethality and dose of the strain ingested. Those that developed hemorrhagic colitis has a
higher risk in developing hemolytic uremic syndrome, which is commonly seen in children and
the elderly.
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Figure 1.1 Comparison of virulence characteristics between non-pathogenic E. coli K-12 and
pathogenic E. coli. Source: (Kuhnert et al. 1995)

1.1.1

Pathogenesis

Intestinal pathogenic E. coli can affect both the small and large bowel but typically the
large bowel (colon). Infection in susceptible individuals can cause inflammatory response,
diarrhea, and/or hemolytic uremic syndrome (Kaper et al. 2004). All pathotypes have similar
scheme of pathogenesis such as colonizing the mucosal site, avoiding host defense, replicating,
and inducing cellular damage. However, different pathotypes will target different mucosal sites
eliciting a broad spectrum of host responses for successful infection.

4
EPEC
EPEC can bind to small bowel enterocytes by an 4rypsin4, intimin. Activation of type III
secretion system (T3SS) allows the translocation of effector proteins into the host cell. EPEC can
insert Tir (translocated intimin receptor) onto host cell membrane for intimate intimin-Tir
binding, leading to accumulation of cytoskeletal protein. Tight junction is loosened and
permeability increases. Nuclear factor-kappaB (NF-κB) is activated, inducing inflammatory
responses. Some EPEC produces enterotoxin, EspC, and is cytotoxic to epithelial cells due to the
cleavage of cytoskeletal and focal adhesion proteins (Navarro-Garcia et al. 2014). These host
responses after interaction with EPEC may cause diarrhea in susceptible individuals.
EHEC
EHEC also carries intimin, a 94 kDa protein encoded by eae that binds intimately with
Tir on the host cell membrane. It targets the colon rather than small bowel enterocytes as
compared to EPEC. The most important virulence feature of this pathotype is the production of
Shiga-like toxins (Stx). This major virulence factor is produced in the colon and reaches the
kidneys

via

the

bloodstream.

High

interaction

of

Stx

with

its

receptor,

Gb3

(globotriaosylceramide) or Gb4 globotetraosylceramide (Gb4) on kidney endothelial cells results
in severe damage and closing of micro vessels due to renal inflammation. As infection
progresses, severe damage of the kidneys can lead to HUS where red blood cells are destroyed
and kidneys fails to function properly. Intestinal epithelial cells are sensitive to Stx and can also
cause damage in the colon. Infected individuals may experience bloody diarrhea and
hemorrhagic colitis. Incubation period is about 3-4 days.
Shiga-toxin alone may not be sufficient for successful infection. Locus enterocyte
effacement (LEE) and pO157 plasmid play important role in EHEC infection for serotype O157.
Additional virulence factors includes Shiga-like toxin 1 (Stx1) and 2 (Stx2), intimin, EHEC
hemolysin, T3SS, catalase peroxidase, serine protease, type 1 fimbriae, p fimbriae, S fimbriae,
F1845, aerobactin, and α-hemolysin. Virulence factors that promote attaching and effacing (A/E)
lesion has been a particular interest. Mutants lacking toxB and/or efa-1 showed significant
reduction in adherence on host surface along with reduced expression and secretion of LEE
proteins (Stevens et al. 2004). When entire LEE is cloned into avirulent E. coli K-12, strains
exhibit attaching and effacing phenotype and can secrete virulence proteins (McDaniel and
Kaper 1997).
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Although intimin plays an important role in colonization, it may not be responsible for
the severity of the symptoms from EHEC. Strains isolated from patients with hemorrhagic colitis
and HUS does not contain the eae gene. Fimbrial adhesins also promote colonization and most
EHEC strains contain both type 1 fimbriae and eae gene. Cytolysins such as α-hemolysin and
EHEC hemolysin (E-hlyA) are toxic to red blood and other human cells, which may be essential
in human virulence. However, most EHEC strains with iutA that encodes aerobactin for iron
acquisition does not synthesize α-hemolysin and would rarely contain E-hlyA that encodes
EHEC hemolysin. Interestingly, all EHEC O157:H7 and 50% non-O157 STEC produce EHEC
hemolysin as as compared to Stx-negative strains. Other proteins encoded by pO157 plasmid
include katP (catalase-peroxidase) to withstand oxidative stress and espP for pepsin A to cleave
human coagulation factor V, but may not have significant role in human infection. pO107
plasmid is rare in non-O157 isolates.

ETEC
Similar to EPEC, ETEC also binds to small bowel enterocytes. After colonization via
fimbrial colonization factors, secretion of heat-stable (ST) and heat-labile (LT) enterotoxins
causes activation of guanylate cyclase (GMP) activity and adenylate cyclase (AMP), which
increases cGMP and cAMP, respectively (Read et al. 2014). Activation of ion channels then
increases secretion of chloride and other ions to cause watery diarrhea.
EAEC
EAEC colonizes the intestinal mucosa and secretes enterotoxins and cytotoxins that cause
mild inflammatory responses and severe mucosal damage. After aggregative adherence fimbriae
bind to intestinal mucosa, dispersin can form a loose surface structure on EAEC that spreads and
penetrates mucosal layer. EAEC flagellin protein is also a surface structure. It promotes
inflammation by activation of IL-8, which disrupts tissue and induces fluid secretion.
EIEC
Mechanism of pathogenesis of EIEC is very similar to Shigella spp. Unlike other
pathotypes, EIEC can invade colonic epithelial cells, avoid phagosomal fusion, and moves from
cell to cell via actin nucleation. Proteins secreted from type III secretion system carries different
functions for successful infection. One of which, is IpaB, and its significance has been associated
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with cytoskeletal rearrangements, invasion, and apoptosis of macrophages and release of IL-1.
EIEC infection may result in colitis, dysentery, and watery diarrhea.
DAEC
DAEC targets small bowel enterocytes by binding to DAF on host cell surface with its
fimbrial 6rypsin6, F1845. Strains can develop long cellular extensions that wrap around the
bacteria, which then activate signal transduction cascades to promote inflammatory responses.
1.1.2

Shiga-like toxins

Stx is an important virulence protein produced by STEC/EHEC. Strains can produce
either Stx1 or Stx2, or both. Total molecular weight is around 68 kDa with a 32 kDa subunit A
and five identical 7.7 kDa subunit B. The B subunit acts as the binding component of Stx to Stx
receptor, globotriaosylceramide or globotetraosylceramide (Gb3 or Gb4) on the surface of
epithelial and endothelial cells. The A subunit plays an active role in protein synthesis inhibition
by cleaving an adenine base from the 28S rRNA of the ribosomal 60S subunit, thus, inducing
cell death. Although Stx1 and Stx2 have similar amino acid sequences, variants of the two types
of toxins are different in terms of binding affinity to host cell receptors, cytotoxicity,
pathogenicity, and host cell response to toxin. Stx2 variants are more diverse than Stx 1. Stx1 has
three subtypes (Stx1a, Stx1b, and Stx1c) and Stx2 has 7 subtypes (Stx2a, Stx2b, Stx2c, Stx2d,
Stx2e, Stx2f, and Stx2g). The four Stx variants, Stx1a, Stx2a, Stx2c, and Stx2d have been
associated with human illness with Stx1a, Stx2a, and Stx2c being the most prevalent in STEC
infected patients reported from 1990 to 2000 (Table 1.1) whereas Stx2e, Stx2f and Stx2g are
primarily associated with illnesses of swine, feral pigeons and cattle, respectively. However,
Stx2f and Stx2g may have the potential to cause human illness due to its DNA sequence
homology with Stx2a and Stx2c. Interestingly other species of Gram-negative bacteria such as
Enterobacter, Citrobacter, Acinetobacter, Campylobacter, and Hamiltonella carry these Stx
variants.
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Table 1.1 stx genes detected from 173 clinically isolated STEC strains
stx gene(s)
stx1a
stx2a
stx2b
stx2c
stx2d
stx1a and stx2a
stx1a and stx2c
stx2a and stx2c

No. of strains (n=173)
28
36
5
9
2
1
6
72

Source: (Eklund et al. 2002)

Location of stx genes in EHEC is different as compared to Shigella dysenteriae. Stx in
EHEC is encoded by lambdoid prophages. Phages are viruses that can infect and reproduce in
host bacteria, which may carry many virulence factors that are essential in bacterial pathogenesis.
EHEC can be susceptible to many different phages that encode stx1 or stx2 genes, so it is very
common for strains to produce both types of toxins. Lambdoid phages can grow lytically, which
kills the host, or lysogenically, where phage chromosome is inserted into the host chromosome
for replication. When stimulated, lysogenic phage will become lytic.

Stx production is

controlled by the activity of pR’, the promoter that encodes downstream genes along with stx1
and stx2 in the late region of the phage (Figure 1.2). However, transcription of pR and pL
promoters occurs only when phage becomes lytic. PL promoter is needed to transcribe N gene, so
pR can transcribe the Q gene for stx expression. During lysogenic growth, pR and pL promoters
are repressed by cI repressor protein.
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Figure 1.2 Stx expression controlled by the phage cycle. Source: (Pacheco and Sperandio 2012)
Stx can be released upon bacterial cell lysis after lytic phage induction. No secretion
system has been found for Stx release in EHEC. After transcription of Q, Q protein interacts with
RNA polymerase where phage genes for cell lysis can be expressed. In this stage, new phage
particles are assembled and released along with Stx. Although Stx can be regulated by phage
repressor activity, stx1 has an additional promoter, pStx1, which is regulated by iron
concentration. Fur repressor protein binds to pStx1, and inhibits the synthesis of Stx. Only under
low iron conditions is when stx1 can be highly expressed. Shimizu et al. (Shimizu et al. 2009)
reported that Stx1 promoter is a dominant regulator in Stx1 production. Wild type can produce
Stx, but mutants lacking pStx1 promoter and Fur binding site failed to produce detectable
amount of Stx even with the addition of mitomycin C. This may explain the differences in
localization of Stx1 and Stx2. Stx1 can be found in the periplasmic space of STEC and Stx2 is
located in the extracellular fraction. Stx2 also has an additional promoter, pStx2, that is located
upstream of stx2 encoded by bacteriophages, but it does not seem to contribute to Stx2
production. Fur operator site was not identified in Stx2 late phage promoter, so Stx2 production
may not be regulated by iron as opposed to Stx1.
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Inactivation of cI repressor protein is needed for lytic growth in order to reassemble,
escape and grow by infecting other bacterial hosts. When the host elicits a SOS response due to
DNA damage, phage takes advantage of this pathway to inactivate cI. Single stranded DNA from
DNA damaging agents activates RecA, which regulates SOS response, interacts with cI repressor
protein and causes it to cleave itself. cI can no longer bind to DNA and allows the expression of
downstream genes for Stx production and release. This regulation of Stx expression plays a role
in pathogenesis of EHEC. After colonization in the colon, leukocytes and neutrophils are
recruited to the site of infection to generate and release reactive oxygen species (ROS). This
activates SOS response in EHEC, which enables production and release of Stx to kill host
immune cells. Similar mode of action has been seen when attacked by unicellular eukaryotes.
Clinically useful antibiotics such as quinolones and trimethoprim that are used to treat diarrheal
infections have been identified to induce SOS response, thus producing and releasing Stx into the
colon. Zhang et al. (Zhang et al. 2000) reported a 17-fold increase in Stx2 concentration after a
3-h incubation of overnight culture with ciprofloxacin (30 ng/ml). After 6 h, Stx2 concentration
increased by 60-fold with more than a 1000-fold increase in plaque forming units (PFU) per
milliliter. Yee et al. (Yee et al. 1993) indicated a 3000-fold increase in Stx2 concentration after
the addition of mitomycin C (2 μg/ml) during mid-log growth. When compared to Stx2 induction
by ciprofloxacin and norfloxacin (125-156 ng/ml), mitomycin C (500 ng/ml) induced the highest
expression of Stx2 after an 18-h incubation of overnight cultures (Laing et al. 2012).
Although there are treatments available to inactivate EHEC in food matrices, it may be
insufficient to inactivate bacteriophages that carry Stx producing gene. Phages thrive well under
harsh conditions and can be found in rivers and sewage systems. Muniesa et al. (Muniesa et al.
1999) reported that Stx carrying phages are more resistant than EHEC after exposure to food
processing treatments such as chlorination and pasteurization. Stx carrying phages are also stable
under food storage and pH conditions. Loss of infectivity is lowest when exposed to neutral pH(s)
from 5-9 at temperatures around 24°C for one month. Upon heat treatment of spiked ground beef,
2 to 4 log reductions of phage titers was not observed until temperatures have reached above
59°C for 10 min (Rode et al. 2011). Low pH(s) and low temperatures may be needed to control
phage infectivity and prevent transduction of virulence genes to susceptible pathogenic and nonpathogenic E. coli hosts (Imamovic et al. 2009). pH and temperature can also affect stability and
activity of Stx toxin. After incubation at 95°C for 1 h, He et al. (He et al. 2012) indicated an 80%
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decrease in cytotoxicity for Stx2a, Stx2c, Stx2d, and Stx2g, which suggested a high thermal
stability for these variants. Stx1 also has a similar thermostability profile and can be inactivated
at 88.5°C in 5 min (Pina et al. 2003). When THP-1 cells (human monocyte cell line) were
exposed to different pH(s) of spiked fruit punch with Stx1, loss of activity is greatest at pH 2
after 90 days of storage. Stx1 activity can be recovered after pH neutralization, which suggests
that Stx1 is most stable at pH 7 (Babu et al. 2008a).

1.2

Foodborne Infections

Illnesses and deaths due to the consumption of contaminated food continues to be a
public threat and global burden, with approximately 600 million cases of foodborne illnesses
caused by 31 foodborne hazards and about 420,000 deaths annually (Havelaar et al. 2015). In
response to recent outbreaks and potential threats of intentional food contamination, efforts have
been made to develop early detection of contaminants and treatments to ensure food safety,
reduce outbreaks, and lessen economic burden. However, limitations of specificity, sensitivity,
and detection time or the lack of an established methodology to target specific contaminants
could be a reason why outbreaks can be unrecognized, unreported, and uninvestigated. Lack of
appropriate resources or an unsuitable biological model for in vivo studies can pose gaps in
understanding the pathogenesis of the foodborne hazards, thus, hindering the efforts of finding
vaccine candidates for prevention. Only with continuous efforts in closing these gaps can we
improve surveillance and control measures against foodborne pathogens.
1.2.1

Host’s Immune Response to EHEC Infection

The two branches of the immune system, innate and adaptive immunity, are designed to
protect the host from pathogens and toxins. Innate immunity is the first line of defense against
viral and bacterial invasion. Pathogens that surpass innate immunity will come in contact with
immune cells from adaptive immunity for successful clearance. EHEC carries pathogen
associated molecular patterns (PAMPs) such as lipopolysaccharide and flagella that are
recognized by host Toll-like receptors 4 and 5 (TLR4 and TLR5) for activation of innate
response. Innate immune cells such as macrophages and natural killer T cells are recruited to the
site of infection and secrete proinflammatory cytokines such as IFNγ to eliminate infection. Ho
et al. (Ho et al. 2013) reported an activation of 2000 IFNγ-stimulated genes in hosts as an
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immune response against EHEC O157:H7 infection. However, Stx produced may suppress IFNγ
signal transduction pathway and allows EHEC to avoid host defense mechanisms. Pearson et al.
(Pearson and Hartland 2014) also reported that non-LEE encoded effectors may be responsible
for the inactivation of proinflammatory cytokines. Suppression of innate immune response such
as inflammation can potentially prevent the activation of an adaptive immune response, hence,
may be the reason behind the difficulties in identifying an antigenic target for vaccine production.
Antibody responses can be variable depending on the individual against intimin, EspA, EspB,
and Stx. Stx is extremely potent in low amounts and may not be antigenic enough to generate a
strong antibody response for protection (Vanaja et al. 2013). Some non-O157 strains of EHEC
also encode a toxin called lymphostatin, which has been thought to interfere with lymphocyte
development (Klapproth 2010). However, Li et al. (Li et al. 2000) reported that sera obtained
from EHEC infected patients showed strong antibody responses against Tir.
The narrow host specificity of EHEC drives the focus on studying host responses against
Citrobacter rodentium due to similar attaching and effacing mechanisms as EHEC. Mice
depleted of neutrophils showed increased colonization in liver and spleen after infection with
Citrobacter rodentium. Neutrophils may play a role in innate immunity by controlling infection
caused by EHEC. Patients infected with EHEC seem to have an increased amount of neutrophils
in feces with high expression of interleukin-8 (IL-8), a chemoattractant for neutrophils.
Expression of IL-8 and other proinflammatory cytokines can be triggered by activation of
nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPK). This promotes
recruitment of granulocytes and inflammation in intestinal tissue, which leads to diarrhea and Stx
release in bloodstream.
Production and release of Stx can prevent macrophage uptake and enhance EHEC
survival. After binding to Gb3 or Gb4 receptors on host cells, Stx is transported from early
endosomes to the Golgi apparatus. Epidermoid carcinoma, astrocytoma, and ovarian carcinoma
cells can be resistant to Stx by promoting lysosomal degradation in macrophages and dendritic
cells after internalization. In sensitive cells, Stx A subunit must be cleaved by furin to become
active and gets transported to the endoplasmic reticulum where the disulfide bond linking the
StxA1 subunit with StxA2-B is reduced. StxA1 can then reach the cytoplasm via retrograde
transport and inhibit protein synthesis, thus triggering a ribotoxic stress response to induce
apoptosis. Gb3 is not expressed on surfaces of normal intestinal epithelium, but recent studies
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have shown that Paneth cells can express Gb3 and may promote Stx internalization and transport.
There are four potential routes of Stx translocation across intestinal epithelium: Gb3-independent
transcytosis, paracellular transcytosis by neutrophils, induction of Gb3 expression and retrograde
transport, Gb3-dependent transcytosis by Paneth cells, and transcytosis by M cells. Little is
known on Stx translocation and intracellular trafficking since there are no appropriate animal
models with similar physiological relevance to human interaction with EHEC (Schüller 2011).
However, a proposed model of EHEC infection in humans is shown in Figure 1.3 where it is
hypothesized that Stx is produced in the intestine and STEC uses M cells to cross the intestinal
barrier. After uptake by macrophages, STEC replicates inside macrophages as it produces Stx to
induce cell death (Etienne-Mesmin et al. 2011).

Figure 1.3 New Model of EHEC infection in humans. Source: (Etienne-Mesmin et al. 2011).
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The final step of infection is Stx induced damage of kidneys, intestine and brain. In the
intestine, STEC relies on M cells to cross intestinal barrier and survives in the lamina propria.
STEC can replicate in macrophages and produce Stx, which leads to cell death. Stx is released
and enters the bloodstream before reaching to target organs resulting in life threating
complications such as hemolytic uremic syndrome. Translocation through M cells and
macrophage uptake are the primary reasons why such a low infection dose (1 to 100 organism) is
sufficient to cause disease (Etienne-Mesmin et al. 2011).
1.2.2

Outbreaks and Recalls

The first foodborne outbreak of EHEC hemolytic colitis was caused by serogroup
O157:H7, dating back to the 1993 and it was due to the consumption of undercooked ground
beef patties. Ground beef, produce, and dairy products have been reported as contaminant with
O157:H7 on the reportable food registry. Sources of O157:H7 contamination have been traced
back to processing and crop growing facility: contamination from manure and irrigation wells,
inadequate process design, and improper sanitation and GMP protocols (Rangel et al. 2005). For
many years, O157:H7 was commonly reported in causing foodborne outbreaks. By 2000, nonO157 serogroups (O26, O111, O103, O121, O45, and O145) were recognized as emerging
pathogens and can be a threat to public health. Since then, methods have been improved to detect
both O157:H7 and non-O157 EHEC in foods (Marlar 2009). CDC reported that EHEC O157 is
accountable for 96,534 cases in the U.S. with 168,466 cases caused by non-O157 (CDC 2012b).
A 2006 multistate outbreak of O157:H7 contaminated spinach infected 199 people in 26 states
with 102 hospitalizations, 31 cases of hemolytic uremic syndromes, and 3 deaths (CDC 2006b).
In 2009, a multistate outbreak involving cookie dough caused 72 cases of colitis. Of which, 32
people were hospitalized and 10 developed hemolytic uremic syndrome (CDC 2009). Source
could not be identified in the 2012 outbreak caused by STEC O145 that infected 18 people,
killing one person (CDC 2012a). In 2015, flour contaminated with STEC O121 and O26
sickened 63 people from 24 states with 17 hospitalizations and one hemolytic uremic syndrome
case (CDC 2016).
Practices and interventions designed to control STEC is critical and can help prevent
contamination and re-contamination during the production. Since cattle are the main reservoir for
STEC, high numbers of STEC can be found in feces and beef hides and can be transmitted to
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carcasses during beef processing (Chaves et al. 2013). Although sanitary dressing and
antimicrobial treatments are followed, prevalence studies have shown that 9% of carcass samples
have tested positive for non-O157 STEC before chilled storage. The industry faces a challenge
because of various reasons, which include (i) STEC can be easily transmitted to farms from
water used to dilute pesticides and fertilizers (Crawford et al. 2014; Allende and Monaghan
2015); (ii) Resistance to sanitizers due to biofilm formation, which demonstrates the
ineffectiveness of routine sanitizing procedures (Wang et al. 2014); (iii) STEC can survive on
stainless steel surfaces for days, which can be transferred to foods upon contact (Møretrø et al.
2010). Given the fact that there are so many contributing factors that can increase the risk of
STEC contamination, the USDA and FDA addressed the importance of developing a better
preventative control along with environmental monitoring programs for hazards such as STEC
(FDA 2016).
Although foodborne illness outbreaks are more of a concern than product recalls,
numerous recalls from potential STEC contamination may lead to an outbreak if the problem has
not been recognized early. In 2010, the FSIS initiated a Class I recall involving contaminated
ground beef products with STEC O26, which may be the cause of 3 colitis cases in New York
and Maine (Hodges 2012). The USDA reported that STEC is responsible for 1.8 million recalls
in 2014 (FSIS 2013). Recalling a food product is not only costly for companies, but it is also
time consuming—clearing products off of market shelves, handling lawsuits, revamping plants,
repairing public relations, and recovering from tainted reputation and lost sales. STEC
contaminated products would be considered as a Class 1 recall where it can result in serious
health problems or death. Recalls are usually voluntary, but if the company refuses to recall its
products, FDA and FSIS have the authority to detain and seize those products.

1.3

STEC Detection Methods

In 1996, it was noted that E. coli serotype O157 may not be the only serotype of concern
(Eblen 2007). Clinical studies have shown the emergence of new serotypes of pathogenic E. coli
that can also produce Stx. Hence, it would be an issue if much attention is given to food testing
for O157 instead of non-O157 STEC isolates. FSIS reported that non-O157 isolates are just as
prevalent as O157 serotypes and caution clinical and food industry professionals to test for the
major non-O157 serotypes such as O26, O55, O103, O111, O121 and O145. Plating on SMAC,
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which ideally can differentiate O157 from non-pathogenic E. coli, is now insufficient to test for
non-O157 due to similar biochemical and phenotypic profile with non-pathogenic E. coli. Since
foodborne illnesses are typically underreported or unrecognized due to the lack of resources to
serotype and serogroup samples, efforts are being made to develop alternative detection methods
that can detect all serotypes and Stx variants.
Emerging technologies for detection of bacterial pathogens plays a vital role in improving
public health, food safety and security (Bhunia 2014). In order to optimize current detection
strategies or develop novel detection platforms, literature must be reviewed to evaluate STEC
testing standards, commercial STEC detection methods, and recently developed platforms that
are not commercially available. Time, specificity and sensitivity are the three key components in
developing a robust detection platform against STEC or other foodborne pathogens.
1.3.1

Conventional Methods

Isolation of O157 STEC requires a non-selective pre-enrichment of food sample in
modified buffered peptone water with pyruvate (mBPWp) or modified tryptone soy broth (mTSB)
incubated at 42°C for 15 to 24 h (Feng et al. 2002; USDA 2015). Overnight cultures are then
plated onto Cefixime Tellurite – Sorbitol MacConkey Agar (CT-SMAC) and Rainbow® Agar
O157 (RBA O157), or concentrated using paramagnetic antibody beads before plating onto
modified Rainbow agar (mRBA) and Sheep Blood agar (SBA). TC-SMAC and chromogenic
agar are incubated for 18 to 24 h at 37°C whereas mRBA requires a 20-24 h incubation at 35°C.
Positive colonies are smooth with a diameter of 1-2 mm, but will produce a certain color and
transparency depending on the selective and differential media used. As for isolation of nonO157 STEC, FDA requires plating of overnight cultures onto Levine’s Eosin-Methylene Blue
(L-EMB) agar and a chromogenic agar before incubation at 37°C for 18-24 h. STEC heart
infusion washed blood agar with mitomycin-C (SHIBAM) is also recommended for isolation of
non-O157 STEC because it can easily differentiate STEC from background microflora. Positive
colonies are flat, producing a dark center with or without a metallic sheen on L-EMB. On
SHIBAM, positive colonies are grey, appearing flat and hemolytic. USDA uses the same
approach for O157 STEC isolation and identification to identify and isolate non-O157 STEC
(USDA 2014). Table 1.2 provides ingredient information that makes media selective and/or
differential for STEC. Furthermore, positive colonies from presumptive identification of STEC
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are confirmed by biochemical and cultural tests (Table 1.3). Traditional methods in isolating and
identifying STEC will take about 2 to 3 days, which may be time consuming and labor intensive.

Table 1.2 Typical selective and differential media used to isolate and identify STEC
Mediaa

Selective

Differential

Key Chemical Agents

Levine’s Eosin-Methylene Blue

Y

b

Y

modified Tryptone Soy Broth

Y

N

Eosin Y and Methylene
Blue
Bile salt and Novobiocin

modified buffered peptone water with
pyruvate
modified Rainbow Agar

N

N

Sodium pyruvate

Y

N

Rainbow® Agar O157

Y

N

Sheep Blood Agar

N

Y

Potassium Tellurite and
Novobiocin
β-galactosidase and βglucuronidase
Sheep Blood

STEC heart infusion washed blood agar
with mitomycin-C

Y

Y

mitomycin C and Washed
Defibrinated Sheep Blood

Cefixime Tellurite – Sorbitol
Y
Y
Sorbitol, Cefixime, and
MacConkey Agar
Tellurite
a
In reference to products from Difco Laboratories, Biolog, Neogen, and Hardy Diagnostics
b

Y-yes, N-no

Table 1.3 Biochemical profile of E. coli serovars
Testa

O157:H7

O6b

O26:H11

O111:H8

O121:H19

O103:H2

Enterohemolysis

+

-

+

+

+

+

Glucose

+

+

+

+

+

+

Inositol

-

-

-

-

-

-

Indole

+

+

+

+

+

+

Methyl Red

+

+

+

+

+

+

Lysine decarboxylase

+

+

+

-

+

+

Arginine dihydrolase

-

-

-

-

-

-

Ornitine decarboxylase

+

+

+

+

-

+

β-galactosidase

+

+

+

+

+

+

β-D-glucuronidase

-

+

+

+/-

+

+/-

Sorbitol

-

+

+

+

+

+

Rhamnose

+

+

-

+

+

+

Sucrose

+

-

+

+

-

+

Melibiose

+

+

+

+

+

+

Arabinose

+

+

+

+

+

+

Mannose

+

+

+

+

+

+

Glycoside

-

-

-

-

-

-

a

In reference to table as outlined from (Atkinson et al. 2012) and (BioMerieux 2002)

b

ATCC reference strain 25922
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Chromogenic medium for STEC screening has become increasingly popular due to its
increased sensitivity and specificity as compared to CT-SMAC and RBA O157 (Parsons et al.
2016). Although CT-SMAC and RBA O157 is widely used in clinical settings, they are not
suitable for detecting non-O157 STEC. CHROMagar O157 is AOAC approved and similar to
other CHROMagars, can rapidly detect isolates through a chromogenic substrate (Piastra and
L’uso 2013). CHROMagar O104 and O157 can effectively isolate and identify O104 and O157
colonies, but would not be able to detect other non-O157 STEC. CHROMagar Microbiology
recently developed CHROMagar STEC for rapid detection of all STEC serotypes. Hirvonena et
al. (Hirvonen et al. 2012) evaluated the performance and usability of CHROMagar STEC,
showing high detection sensitivity against STEC O26, O111, O121, O145, and O157.
Interestingly, STEC capable of growing on CHROMagar must have tellurite resistance gene.
1.3.2

Antibodies

Multiple virulent targets of EHEC (or STEC) have been explored for antibody production
as potential vaccine candidates and antibody-based detection tools to protect the public health.
Some of which includes Stx1 and Stx2 proteins, STEC O groups, intimin, Tir, translocator of
type III secretion system—EspA and EspB, EHEC hemolysin, and lipopolysaccharide (LPS).
The Stx, is one of the most important virulence factor in STEC pathogenesis. Progress has been
made to develop better antibodies targeting all subtypes of Stx1 and Stx2 for development of
detection assays (Rocha et al. 2012; He et al. 2013a; He et al. 2013b; Skinner et al. 2013).
Commercially available antibodies have shown cross reactivity between Stx1 and Stx2 subtypes
and limited specificity in identifying all subtypes of the toxin. Sensitivity can also be affected
from complex matrices of food and environmental samples, so enrichment and concentration of
culture supernatants may be needed to improve detection (He et al. 2011). Medina et al. (Medina
et al. 2012) developed polyclonal antibodies (pAb) against O antigens of the top six non-O157
serogroups, which reacted with target strains. However, anti-O26 and anti-O103 showed some
cross reactivity with O145, O103 and O26 strains, producing false positive results. Sensitivity is
low and pAbs against O groups showed strongest response when cultures are grown to 105 CFU
after enrichment (Hegde et al. 2013). Intimin and EspA were used to develop single chain
fragment variable antibodies and can only react to γ intimin of O157:H7 and EspA from EHEC
strains, respectively (Kühne et al. 2004). Joris et al. (Joris et al. 2013) developed serum
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antibodies against intimin, Tir, EspA, EspB and Stx1/2 from naturally and experimentally
infected cattle, showing strong reactions with EspA and EspB. These serum antibodies were
designed for EHEC screening of infections in cattle to reduce contamination of carcasses. EHEC
hemolysin, a 107-kDa cytolysin, was used to develop pAbs, which reacted with EHEC
hemolysin positive strains. However, they also showed cross reactivity with α-hemolysin
positive strains (Schmidt et al. 1999). Antibodies against LPS, an endotoxin produced by Gramnegative bacteria that induces septic shock, have also been investigated as a potential vaccine or
detection tool to prevent STEC (Wang et al. 2011). However, anti-LPS cannot differentiate
Gram-negative bacteria by species or detect pathogenic from non-pathogenic Gram-negative
bacteria. Santos et al. (Santos et al. 2010) reported that anti-O111 LPS can react with O111
strains, but specificity is limited because it cannot detect other EHEC serogroups.
1.3.2.1 Antibody-based detection Methods
Antibody-based methods such as ELISA, lateral flow, flow cytometry and biosensors
have been widely used to screen for STEC in food and environmental samples. Following
USDA or FDA guidelines, immunological assays can detect the pathogen or biotoxin either
directly from the food sample or after a purification step using paramagnetic beads coated with
antibodies against the target. Gb3 host receptor for Stx, anti-Stx, anti-O or H antigen of STEC
serotypes antibodies have been used to capture and detect Stx or STEC strains. Ashkenazi and
Cleary (Ashkenazi and Cleary 1989) developed sandwich ELISA that can rapidly detect Stx1
using natural receptor Gb3 and anti-Stx1, peroxidase conjugated anti-mouse secondary antibody,
and orthophenylene diamine as substrate for color development. Detection limit was about 0.2 ng
of purified toxin and there was no cross reactivity with cholera, heat labile and heat stable
enterotoxins, Clostridium difficile toxins and other cytotoxins produced by foodborne pathogens.
As mentioned previously, O groups of non-O157 STEC can also be used to design antibodies for
ELISA detection and Hegde et al. (Hegde et al. 2013) reported 100% specificity for O103, O111,
and O121 strains, 98.2% specificity for 26 and O45, and 99.1% specificity for O145 serogroups.
Limit of detection was reported to be 1 to 10 CFU/g of ground beef sample. Wang et al. (Wang
et al. 2016) took a different approach to detect Stx and O157 antigen by using lateral flow assay
with nano colloidal gold particles conjugated with monoclonal anti-Stx and anti-lipid A
antibodies. STEC strains were treated with ciprofloxacin (100 ng/ml) at 37°C to induce Stx
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production and detection time was improved where 105 CFU/ml of spiked ground beef can be
detected within 3 h. Assay was highly specific without cross reactivity. Flow cytometry and
biosensors have been a popular method for bacterial detection because of its rapid and sensitive
design that can directly detect the infectious agent from the food sample. Flow cytometry can
detect STEC using fluorescence labeled oligonucleotide probes against E. coli 16S rRNA, Alexa
Fluor 488 labeled rabbit anti-O antigen of the top six STEC groups, and FITC-labeled rabbit
anti–E. coli O157:H7 (Raybourne 2001; Hegde et al. 2013; Xue et al. 2016). Although this
method can detect 1 to 104 CFU/ml of STEC in 1 to 2 h following enrichment, cross reactivity
was observed among the O serogroups and the 16S rRNA between E. coli and Shigella. Carbon
nanomaterials, quantum dots, and oligonucleotide-modified primary antibodies have been used
to develop 19 rypsi-based biosensors to detect STEC. Oligonucleotide-modified primary
antibodies, however, is difficult to prepare, which makes 19rypsi-PCR an unattractive method to
employ. Carbon nanotubes have been used as a rapid, sensitive, and label-free detection method
for genomic DNA of O157:H7 (Subramanian et al. 2012). Due to its high electrical properties,
shift in voltage was observed when genomic DNA of O157:H7 was captured by oligonucleotide
probe coated on carbon nanotube platforms. Quantum dots are semiconductor nanocrystals with
broad excitation spectrum. It can be conjugated to anti-Stx antibodies to probe for the presence
of Stx in samples with mixed cultures. However, high background signals and low sensitivity
have been reported, which also makes it widely unattractive in bacterial and biotoxin detection
(Zhu et al. 2014).
1.3.3

Stx Sensitive Mammalian Cells

Histopathological examinations of infected patients from the 1993 outbreak linked to
contaminated hamburgers suggested that vascular endothelial cells are target cells for Stx. Cells
that have natural receptor to Stx, Gb3 or Gb4, like vascular endothelial cells was expected to have
similar sensitivities when the host encounters the toxin. Ramegowda and Tesh (Ramegowda and
Tesh 1996) studied the effects of purified Stx on human peripheral blood monocytes,
differentiated and undifferentiated human myelogenous leukemia cell lines THP-1 and U-937.
Undifferentiated THP-1 cells were shown to be more sensitive to Stx while the differentiated
THP-1, U-937 and human peripheral blood monocytes were resistant to Stx. Cell lines resistant
to Stx either had low levels of Gb3 or reduced Gb3 expression after the addition of differentiation
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agents. Different cell types will have different mechanisms in regulating Gb3 synthesis,
internalization and intracellular transport of Stx. Levels of proinflammatory cytokines produced
such as tumor necrosis factor alpha (TNF-α) and interleukin 1β (IL-1β) from different cell types
in response to the toxin may also contribute to the difference in sensitivity.
Although some may have thought that endothelial cells are primary target cells, there are
other Stx-sensitive cells in the kidney that can lead to proteinuria, dehydration, and renal failure
(Obrig and Karpman 2012).

Neutrophils, monocytes, B-lymphocytes, platelets and red blood

cells are not sensitive to Stx due to the low levels of Gb3 receptors for Stx or the lack of nuclei in
red blood cells. It was proposed that Stx could bind to neutrophils, platelets, and red blood cells
to reach the kidney because of their lack of sensitivity to the toxin. Different cell types will have
different Stx internalization and signaling mechanisms. Stx can bind to receptors, Gb3 or Gb4, on
membrane surface before entry via endocytosis, which induces aggregation on endothelial cells.
Stx also binds to monocytes using Gb3 receptors and binding affinity increases with the presence
of LPS. But unlike the mode of action in endothelial and epithelial cells, Stx induces production
of proinflammatory cytokines rather than inhibition of protein synthesis. Interestingly,
neutrophils have TLR4 instead of the typical Gb3 host receptor for Stx, which is also the receptor
that recognizes LPS (Brigotti et al. 2013). In response to Stx, activated neutrophils release
proteases and reactive oxygen species. There are many different Stx sensitive cell types in the
kidney such as human glomerular podocytes, endothelial, mesangial cells, and extraglomerular
cells. All exhibit different levels of Gb3 expression and sensitivity to Stx.
O’Brien and Holmes (O'Brien and Holmes 1987) reported that only certain cell lines are
sensitive to Stx such as HeLa and Vero cells whereas Hep-2, WI-38, baby hamster kidney,
Chinese hamster ovary (CHO), Y-1 adrenal, L, and human melanoma cell lines are slightly
resistant or resistant to Stx. HeLa and Vero cells have been widely used to study pathogenesis of
STEC. The very first studies in understanding Stx mode of action and discovering Gb3 as natural
receptor for Stx were by running bioassays using HeLa and Vero cells. Their high level of Gb3 or
Gb4 receptors on surface membrane, endocytotic internalization and efficient translocation to
ribosome make these cells extremely sensitive to Stx. Because Vero cells are so sensitive to Stx,
often times, Stx has been referred as Vero toxins. Konowalchuk et al. (Konowalchuk et al. 1977)
developed the Vero cell assay, which is currently the gold standard to confirm the presence of
STEC. Vero cells did not recover after being treated with crude Stx and significant
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morphological changes were observed. Roberts et al. (Roberts et al. 2001) developed a
cytotoxicity assay for E. coli O157:H7 using the Vero cells. Maldonado et al (Maldonado et al.
2005) used Vero cell assay to evaluate the cytotoxicity of several food and environmental E. coli
isolates.
1.3.3.1 3D Cell Culture
Two dimension (2D) cell culture is the traditional method used in cell-based assays, however, it
cannot provide physiologically relevant information as human cells are typically grown in 3D
(Banerjee and Bhunia 2009; Edmondson et al. 2014). Although preparation of a 2D cell culture
system is much faster than seeding cells 3 dimensionally, 2D cell-based assays may provide
misleading results that could be the reason for the conflict of ideas in elucidating the
pathogenesis of STEC in humans. Clinical trials have also proven that 2D cell culture screening
of compounds for drug discovery is accountable for the high percentage of drug failure (90%).
Since data collected from mice models showed no correlation with 2D cell culture testing, a
difference in dimension can potentially affect cellular response to the analyte (i.e drug
compound). It has been increasingly evident that 3D cell culture systems could be superior to the
traditional 2D format in terms of viability, gene expression, and cellular behavior. Studies have
suggested that 3D cells are morphologically different than 2D cells where aggregates or
spheroids are grown in an extracellular matrix, on the surface of the matrix, or in suspension
medium. This allows cells to interact with each other that mimic the natural environment of the
human model. Rate of proliferation is dependent upon cell line and matrix used, however, studies
have shown that 3D cells typically have reduced proliferation rates as compared to 2D cells.
Moreover, cell viability can be significantly different among dimension (Banerjee et al. 2008).
3D cell culture systems have been applied in cell-based biosensors where these cultured cells are
the sensing element. Since 3D cell culturing mimics physical and physiological properties of in
vivo conditions, cell-based biosensors in a 3D format would be ideal in detecting pathogens or
toxins, drug screening, and evaluating cell–biomaterial interactions.
1.3.3.2 Cell-based Assays
Proliferation, viability, and cytotoxicity assays can monitor health and response of cells
after treatment with an infectious agent (Stephenson and Benedick 2010). Pharmaceutical
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industry routinely uses cell-based assays for drug discovery screening, but the assay can also be
used to understand mechanisms of pathogenesis.

Selection of assay method and cell line

depends on the objective of the experiment. Proliferation assays such as 3-(4,5-dimethyl-2thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) or 2,3-bis-(2-methoxy-4-nitro-5sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) metabolic staining, 2-(4-Iodophenyl)-3-(4nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-1) DNA labeling,
and cleavage of carboxyfluorescein diacetate succinimidyl ester (CFSE) monitors growth rate,
number of cellular divisions, metabolic activity or DNA synthesis (Ngamwongsatit et al. 2008).
Viability or Cell Counting assays uses dyes such as Trypan blue or Calcein-AM to membrane
integrity of cells. Healthy cells with intact membrane will appear bright under the microscope
whereas dead or damaged cells will take up Trypan blue and appear blue. Non-fluorescent
Calcein-AM will fluoresce and appear bright green after cleavage by cytosolic esterases from
live cells with intact membrane. Alkaline phosphatase (ALP) and lactate dehydrogenase (LDH)
are two biomarkers for cell cytotoxicity (Bhunia and Wampler 2005). Only a selected number of
cell lines carry the 100-165 kDa ALP such as Ped-2E9 B lymphocytes, HeLa epithelial cells, and
HepG2 liver cells. Damage of mammalian cell membrane from infectious agents can induce the
release of this glycosyl-phosphatidylinositol bound protein, which can be detected using ρnitrophenyl phosphateor or 4-Methylumbelliferyl phosphate disodium as the substrate for a
colorimetric or fluorometric signal. LDH is a smaller intracellular enzyme, 35 kDa, carried by
most mammalian cells. The release of LDH due to membrane damage by infectious agents can
be detected using a substrate mix of NAD+, sodium lactate, diaphorase, and tetrazolium.
Annexin V-Phycoerythrin staining, DNA fragmentation, caspase activity, and mitochondrial
cytochrome c release can also be used to monitor induction of apoptosis as indication of the
presence of infectious agents.
1.3.3.3 Cell-based Biosensors
Mammalian cell-based biosensors are of particular interest because it is a cost effective
approach in measuring the functionality and toxicity of an analyte. Cell lines using lactate
dehydrogenase, calcium and fluorescence signaling, for example, have been used to detect Stx
and EHEC O157:H7. Roberts et al. (Roberts et al. 2001) developed an assay that could
distinguish STEC from non-STEC strains through the release of lactate dehydrogenase mediated
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by Stx induced Vero and Hep-2 cell death. The gold standard Vero cell assay usually takes about
48 to 72 hours to complete using microscopy to examine cytotoxicity effects. Roberts et al.
(Roberts et al. 2001) improved the assay by reducing detection time to 12-16 h with confirmation
of absence or presence of Stx genes using PCR and Riboprinting analysis. The improved
colorimetric assay was also used to evaluate the cytotoxicity potential and genotypic
characterization of STEC isolates from food and environmental sources (Maldonado et al. 2005).
Results suggested that a high percentage of cytotoxicity correlates with the presence of stx genes,
however, Stx negative isolates that express hemolysin A (hlyA) can also induce a moderate
degree of cytotoxicity. More recently, Quiñones et al. (Quiñones et al. 2009) developed a
mammalian cell biosensor using a genetically modified Vero cell line with a destabilized variant
(half-life, 2 h) of the enhanced green fluorescent protein (Vero-d2GFP) that could detect 100
ng/ml of Stx2 in 16 h after sampling in pure cultures. Upon Stx exposure, Vero-d2GFP loses
fluorescence due to Stx mediated inhibition of protein synthesis, which can be detected using a
fluorometer. Although the assay has a low detection limit of 100 ng/ml of Stx2, detection time is
comparable to the previously mentioned lactate dehydrogenase release assay. In another study,
Wang et al. (Wang et al. 2015) used genetically modified B cells, Marc 29F8, that produces IgM
specifically to LPS of O157:H7 for O157:H7 detection. After binding to O157:H7, B cells
trigger calcium release activated channel (CRAC) in response to antigen recognition where Ca2+
influx can be detected in minutes using Fura-2 calcium binding probe. B cell biosensor using
Ca2+ signaling has a detection limit of 102 CFU/ml that could detect viable O157:H7 within 10
min from pure cultures. However, sensitivity and specificity of the assay was affected for food
applications where background microflora and food particulates may be the cause in the
difference of responses observed between pure and mixed cultures. Interestingly, higher
concentrations of O157:H7 caused a drop in signal response and interfered with the signaling
pathway to activate CRAC. B cell expansion and apoptosis may have occurred before activation
of CRAC where the amount of Ca2+ released is under undetectable limits. This sets a detection
range of 102-105 CFU/mL against STEC O157:H7.
1.3.4

Molecular-based Detection Methods

Molecular based methods are attractive because they can rapidly detect specific genes
that can differentiate STEC from non-STEC. Jinneman et al. (Jinneman et al. 2003) developed a
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real-time PCR-based assay that could detect and differentiate O157:H7 serotype from non-O157
STEC. They used the O157:H7-specific uidA, stx1 and stx2 as their gene targets and positively
detected all STEC and O157:H7 tested. Fode-Vaughan and colleagues (Fode-Vaughan et al.
2003) developed a direct PCR detection of stx1 and stx2, which allowed for faster detection of
STEC in enrichment cultures without the need to subculture on selective and differential media.
They showed that direct PCR of stx gene from samples, without enrichment, could detect 1-10
CFU/ml from spiked groundwater and milk. However, direct PCR could not detect stx genes
from milk samples containing 100 cells, which may be due to PCR inhibitory effect of milk
components. Nejman-Falénczyk et al. (Nejman-Faleńczyk et al. 2015) detected STEC from pure
cultures by targeting the stx1 and stx2 genes with probes labeled with fluorescent agent 6carboxylfluorescein and black hole quencher. They were able to detect 10 pg of genomic DNA
for both stx1 and stx2 genes in 1.5 h without the need of running gel electrophoresis. The genes
eaeA and hlyA have also been targets for STEC detection in food and environmental isolates
(Maldonado et al. 2005). Madic et al. (Madic et al. 2011) used a two-step procedure to isolate
STEC DNA from raw-milk cheese using immunomagnetic beads and detected it using PCR that
targeted the O antigen gene cluster of STEC O26, O103, O111, O145, and O157. Fratamico and
colleagues (Fratamico et al. 2017) detected STEC O26, O103, O111, O145, O45 and O157 from
ground beef samples targeting O antigen genes, stx1, stx2, and eae following a 10-15 h
enrichment with immunomagnetic separation. However, samples spiked with two O111:NM
strains could not be isolated and confirmed with this method. Recovery of O111:NM after a 24 h
enrichment with immunomagnetic separation from artificially inoculated ground beef samples
were also lower than other serogroups detected using the multi-plex PCR assays targeting stx1,
stx2, eae and wzx genes (Fratamico et al. 2011).
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EARLY DETECTION OF SHIGA-TOXIN PRODUCING
ESCHERICHIA COLI USING 3D VERO CELL-BASED ASSAY

2.1

Abstract

Current culture methods such as the traditional Vero cell assay, although sensitivity, are
lengthy taking 48-72 h to determine STEC presence. In this study, we investigated if 3D CARD
(cell-based assay for rapid high-throughput detection of Shiga-toxin producing Escherichia coli)
could be used for rapid screening and detection of Shiga-toxin producing Escherichia coli
(STEC) by measuring release of lactate dehydrogenase from Vero epithelial kidney cell line as a
biomarker for cytotoxicity to differentiate these from non-STEC. Vero cells were exposed to
antibiotics (mitomycin C, ciprofloxacin, or polymyxin B) and growth medium (LB, DMEM,
mTSB, or EC broth) at 37°C for 16 h with 5% CO2. Sensitivity, specificity, and detection time
was determined by exposing 2D and 3D Vero cells to 17 isolates of STEC and 10 isolates of
non-STEC at 37°C for 2-24 h under 5% CO2. Ground beef samples (32 ± 3.2 g) were artificially
inoculated with STEC strain 204P (6.7 ×102 ± 2.1 ×102 CFU/ml) and enriched in mTSB at 42°C
for 15 h before exposure to 3D Vero cells for 6 h. After evaluating three antibiotic treatments,
four growth media, and two cell culture platforms, uninduced bacterial cells resuspended in LB
were found to be suitable for building 3D CARD in generating high percent cytotoxicity similar
to induced cells by mitomycin C (2 µg/ml) and ciprofloxacin (100 ng/ml) treatment. CARD can
detect STEC after 6 h post infection with percent cytotoxicity ranging from 33%-79%, which is
66 h faster than the traditional 2D platform, when tested against known laboratory strains of
STEC. The percent cytotoxicity against non-pathogenic E. coli, Salmonella, Listeria, Citrobacter,
Serratia, and Hafnia is below the established cytotoxicity cutoff value of 15%, showing low
cytotoxicity response. STEC inoculated ground beef samples (n=27) gave 38-46% cytotoxicity
with CARD and bacterial isolates (n=42) on SMAC plate were further confirmed to be stx1 and
stx2 positive in a multiplex PCR. CARD-based identification of samples resulted low falsepositive results. This is the first screening technology against STEC relying on host pathogen
interaction that can complement other genomic and proteomic detection in isolating and
detecting STEC from food samples as a preventative control for foodborne outbreaks.
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2.2

Introduction

Shiga-toxin producing Escherichia coli (STEC) is of major concern, especially being known as
one of the top five foodborne pathogens that is responsible for a high number of hospitalizations
in the United States each year (Scallan et al. 2011). STEC comprise of more than 200 serotypes,
and are Gram-negative, rod shaped, non-spore-forming bacteria that lives in the intestinal tract of
animals, contaminated soil and surface waters. However, most do not cause serious illness unless
it contains the Locus of Enterocyte Effacement (LEE) Pathogenicity Island that carries eae and
the genes for type III secretion system (T3SS). Under severe cases, infection can progress and
lead to hemolytic uremic syndrome (HUS). The major serotypes of concern are O26, O121,
O103, O157, O45, and O145, which were responsible for several foodborne outbreaks
(Martineau et al. 2001; Tong et al. 2015). O157 STEC can be differentiated based on the ability
to ferment sorbitol. Sorbitol-positive species can either be non-O157 STEC or non-STEC, and
the sorbitol-negative species are O157 STEC (CDC 2006a; Parsons et al. 2016). STEC can
produce two types of Shiga-like toxins, Stx1 and Stx2, which can be further characterized into
subtypes, Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2f, and Stx2g, where Stx2a and
Stx2c are the most prevalent variants that have been associated with HUS in patients (Sheoran et
al. 2003). Therefore, advanced technologies and methods should be exploited for rapid detection
of STEC including emerging pathogens that express stx1 and stx2 genes in food samples to
reduce the risk of food contamination, prevent foodborne outbreaks, and alleviate financial
burden in the food industry.
Although mortality is low, consumption of food contaminated with STEC leads to high
morbidity (Karmali et al. 2010; CDC 2012b; Sperandio and Nguyen 2012). Continuous efforts
are being made to reduce the high morbidity rates by developing microbial pathogen and
biotoxin detection platforms for food application purposes as an important control measure in
improving food safety and diagnostic testing. The National Advisory Committee on
Microbiological Criteria for Foods (NACMCF) regularly reviews microbiological criteria and
offers scientific recommendations to federal agencies such as the United States Department of
Agriculture (USDA) and Food and Drug Administration (FDA) to improve regulation and
methodologies for food safety. According to FDA and USDA-FSIS, a zero-tolerance policy must
be enforced in the US where raw commodity must be free of STEC before being sent off to the
market (Babsa et al. 2015; FSIS 2016; Brusa et al. 2017). Likewise, the European Food Safety
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Authority (EFSA) has similar regulation. The presence of STEC in raw meat and fresh produce
would be a significant public threat. Improper handling of food or preparation practices and
exposure to cattle farm can lead to STEC infection. For instance, Kassenborg and colleagues
performed a matched case-control study from 5 FoodNet sites and identified the following three
risks associated with sporadic O157 infections: consumption of undercooked ground beef and
locally slaughtered beef, eating at table-service restaurants with improper handling and serving
of undercooked ground beef, and residential exposure to cattle farms (Kassenborg et al. 2004).
Infectious doses as low as 1-2000 ng of Stx2a and 400 ng of Stx1a, extracted and purified from E.
coli K-12 DH5α containing plasmid that encodes stx1 and stx2, can cause illness (Tesh et al.
1993; Russo et al. 2014).
Traditional culturing methods, although accurate, are tedious and lengthy. Further,
standardized methodology is only established for STEC O157 serotype, limiting the ability to
detect and quantify non-STEC O157 serotypes. Biochemical and physiological characteristics
can be used to differentiate STEC O157 from non-pathogenic E. coli. However, such methods
cannot be used to distinguish non-STEC O157 from non-pathogenic E. coli. Genomic and
proteomic tools such as PCR and ELISA are widely used, but fails to differentiate viable from
dead cells, have limited specificity due to cross-reactivity of antibodies, and can be prone to
inhibitors from the complex food matrices (Tate and Ward 2004; Michael A. Grant 2011;
Medina et al. 2012; Schrader et al. 2012). Mammalian cell-based assays are of particular interest
because of its cost effective approach in measuring the functionality and toxicity of the analyte
(Banerjee and Bhunia 2009; 2010). The mammalian cell-based assays may be suitable for rapid
high throughput screening to rule out negative samples while positive samples can be examined
by a confirmatory test, to achieve results in an hour to a day (Bhunia 2014).
Cell-based assay for rapid high-throughput detection of Shiga-toxin producing E. coli
(CARD) was modified at Purdue University to rapidly detect and differentiate STEC from nonpathogenic E. coli relying on the release of lactate dehydrogenase (LDH) from Vero cells as a
biomarker for cytotoxicity (Roberts et al. 2001; Maldonado et al. 2005). This bioassay is the gold
standard method that screens for Stx positive samples in 48-72 h by examining the health of
Vero or HeLa epithelial cells under an inverted microscope (Konowalchuk et al. 1977). Roberts
et al. (Roberts et al. 2001) improved the assay by reducing detection time to 12-16 h. Maldonado
et al. (Maldonado et al. 2005) used the same assay to evaluate the cytotoxicity profile of STEC
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isolates from food and environmental sources. More recently, Quiñones et al. (Quiñones et al.
2009) modified the bioassay using a genetically modified Vero cell line with a destabilized
variant (half-life, 2 h) of the enhanced green fluorescent protein (Vero-d2GFP) that could detect
100 pg/ml of Stx2 in 16 h. Although the assay has a low detection limit, detection time is
comparable to the previously mentioned LDH release assay. Interestingly, commercial and
newly developed cell-based assays only used Stx protein, rather than STEC bacteria as the
analyte of the detection method. As a work shift (6-8 h) is typically desired by both industry and
government agencies, we proposed to extend the current research and modify the platform with
the goal of reducing the overall detection time and evaluate the sensitivity and specificity of
CARD to detect STEC bacteria.
In this study, CARD was modified and validated with pure cultures to select optimal
conditions (type of cytotoxicity assay, media, antibiotics, cell culture dimension, time) for
evaluating cytotoxicity potential of STEC. Luria Bertani (LB) broth without a pre-induction
agent such as antibiotics was found to be a suitable enrichment method while achieving low
LDH background response for CARD detection from artificially contaminated ground beef
samples. Samples were further confirmed with traditional plating method on SMAC and a
multiplex PCR targeting stx1 and stx2. Overall, results support application potential of 3D
CARD in detecting STEC from food samples in 6 h.

2.3
2.3.1

Materials and Methods
Bacterial cultures and media

Frozen stock cultures (Table 2.1) were sub-cultured in modified tryptone soy broth
containing 0.15% bile salt, 0.4% dipotassium hydrogen phosphate, and 0.25% glucose (mTSB,
Becton Dickinson, Franklin Lakes, NJ) and were maintained on Brain Heart Infusion plate agar
(BHI, Becton Dickinson) for 1 month at 4°C. For fresh cultures, isolated colonies were
inoculated into mTSB and grown at 42°C for 15 h with shaking at 120 rpm. To confirm and
verify cultures, isolates were streaked on Modified Oxford Agar (MOX, Neogen, Lansing, MI),
Xylose Lysine Tergitol 4 (XLT4, Becton Dickinson), Sorbitol McConkey Agar (SMAC, Becton
Dickinson) and RAPID’Enterobacteriaceae Medium (Bio-Rad, Hercules, CA).
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2.3.2

Cell culture

African green monkey kidney (Vero) cell line (ATCC CCL-81) were purchased from the
American Type Culture Collections (ATCC) and maintained in Dulbecco’s modified Eagles
medium (DMEM) (Sigma, St. Louis, MO, USA) with 10% fetal bovine serum. For all
cytotoxicity assays, about 3.0 ×104 cells were grown as monolayers in 48 well plates at 37°C
with 5% CO2 under humidity for 24 h. Cell monolayers were trypsinized with 0.25% of 29rypsin
(Sigma) as described in ATCC protocol and cell counts were determined by Trypan blue (0.4%)
staining (Sigma). For 3D cell culture, about 3.2 ×104 cells were embedded in a collagen matrix
(0.7 mg/ml) containing 50 μl PBS, 113 μl collagen I, 2.5 μl NaOH, and 335 μl DMEM (Sigma)
as described (Banerjee et al. 2008). DMEM with 10% fetal bovine serum (FBS) was added after
a 30-min incubation at 37°C in 5% CO2 to allow for complete gelation.
Table 2.1 Bacterial cell populations in mTSB (USDA enrichment) cultured for 15 h
Culture
Escherichia coli

Isolatea

Serotype

PCRb

Cell densityc

489

O157:H12

-

4.00×108±7.48×107

490

O157:H19

-

5.83×108±1.24×108

467

O5:NM

stx1

4.90×108±3.67×108

HSC7

O111:H8

stx1

5.00×108±5.35×107

SJ3

O26:H11

stx2

8.03×107±6.18×106

SEA13A72

O157:H7

stx2

2.77×108±1.11×108

488

O157:NM

stx2

4.07×109±1.81×109

HSC23

O91:H21

stx2

3.57×108±4.50×107

B1409-C1P

O157:H7

stx2

2.14×108±1.52×108

B1409-C1

O157:H7

stx2

1.37×108±5.14×107

505B

O157:H7

stx1/2

3.90×108±5.10×107

204P

O157:H7

stx1/2

4.57×108±1.15×108

EDL933

O157:H7

stx1/2

4.30×108±7.26×107

HSC27

O111:H8

stx1/2

6.63×108±1.08×108

HSC16

OR:H7

stx1/2

5.77×108±5.31×107

SJ12

O103:H11

stx1/2

6.37×107±9.74×106

SJ9

O45:H2

stx1/2

3.97×107±4.19×106

SJ18

O121:H19

stx1/2

4.46×108±2.86×108

Table 2.1 continued
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SJ23

O145:NM

stx1/2

1.02×108±6.98×106

13ENT512

Heidelberg

-

1.84×109±4.92×108

-

Kentucky

-

1.77×109±2.49×108

-

Tennessee

-

Listeria monocytogenes

F4244

4b

-

NGd

Listeria innocua

F4248

-

-

NG

Citrobacter freundii

43864

-

-

2.37×101±6.34×102

8090

-

-

2.37×101±1.09×101

8100

-

-

3.20×103±2.16×104

43862

-

-

2.60×104±7.79×105

18066

-

-

2.37×104±5.25×105

Salmonella enterica

Serratia marcescens

Hafnia alvei

2.80×109±3.74×108

a

Isolates were obtained from Auburn University, Food and Drug Administration, Agri-Food Canada, Center for
Disease Control and Prevention and American Type Culture Collection

b

stx1 and stx2 gene based multiplex PCR was performed with initial denaturation at 95°C for 2 min, denaturation at
95°C for 1 min, annealing at 57°C for 1 min, and elongation at 72°C for 35 seconds

c

Isolates were plated on SMAC to enumerate bacterial cell density

d

NG, no growth

2.3.3

Determination of optimal Vero cell number for cytotoxicity assay

Lactate dehydrogenase and alkaline phosphatase (ALP) release were evaluated as
described previously (Maldonado et al. 2005); (Roberts et al. 2001), with slight modifications.
Optimal target cell number for LDH cytotoxicity assay was determined to ensure LDH activity is
within the linear range. Two-fold serial dilutions of Vero cells (2.6×106 cells/well) were plated
twice in triplicate wells of a 48 well plate. Plates were incubated overnight at 37°C with 5% CO2
before treating high controls with 10 μl of Triton-X 100 (2%) and low controls with 10 μl of
sterile water. Plates were incubated for 45 min at 37°C with 5% CO2 before transferring 50 μl of
aliquot to a 96 well plate. A 50 μl of reaction mixture (Pierce Biotechnology, Rockford, IL, USA)
was added to all samples and incubated in the dark for 15-20 min. Absorbance at 490 nm and
680 nm were measured using a spectrophotometer.
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2.3.4

Cytotoxicity assay

Vero cells (3.2 ×104 cells) were seeded in 48 well plates and incubated at 37°C with 5%
CO2 for 24 h. Cells were washed with DMEM before treatment with bacterial culture
preparations. Samples were diluted 3:2 in serum free DMEM medium before incubation at 37°C
with 5% CO2 for 2 h to 16 h. Cell supernatants were collected after centrifugation (1800 ×g for 3
min) and loaded onto a sterile 96 well plate. Samples (50 μl) were mixed with LDH reaction
mixture (50 μl) containing diaphorase, NAD+, sodium lactate, and iodophenyl-nitrophenylphenyltetrazolium chloride (Pierce Biotechnology, Rockford, IL, USA) or ALP reaction mixture
(200 μl) containing ρ-nitrophenylphosphate (PNPP; Sigma)). Plates were incubated for 15-20
min in the dark at room temperature before taking measurements at absorbance 490/680 nm for
LDH release and 405 nm for ALP release using a microplate reader (Epoch, BioTek, Winooski,
VT). High controls treated with Triton X-100 (2%) for 45 min and low controls treated with
serum free DMEM+Luria Bertani broth (LB) were used to calculate percent cytotoxicity values
of positive (O157:H7 strains 204P or EDL933) and negative controls (O157:H12 strain 489 or
O157:H19 490) and experimental samples. To visualize cytopathic effect from treatments, cells
were fixed with formaldehyde (4% in PBS, Sigma) and stained with Trypan blue (4%, 1:2
dilution, Corning, Waltham, MA, USA) solution for 3 min. Images were captured at 400X
magnification.
2.3.5

Media and antibiotic selection

Four different growth media and three antibiotics were evaluated to test for interference
with the assay. LB broth (300 μl, 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl), modified
Tryptone Soy Broth (mTSB, 300 μl, Becton Dickinson, Franklin Lakes, NJ), EC broth (300 μl,
Becton Dickinson), and Dulbecco’s modified Eagles medium (DMEM, 300 μl, Sigma) were
added to 200 μl of DMEM before exposure to Vero cells and incubated for 16 h at 37°C in 5%
CO2. For antibiotic treatment, Vero cells were exposed to 500 μl of DMEM containing
polymyxin B (PolyB, 50 μg/ml, Sigma), mitomycin C (MitoC, 24 ng/ml, Sigma), or
ciprofloxacin (Cipro, 1.2 ng/ml, Sigma) for 16 h at 37°C in 5% CO2. To verify the activity of
antibiotics, Vero cell supernatants were tested against STEC EDL933 O157:H7 (108 CFU/ml) on
BHI. Since PolyB can potentially interfere with the assay and can give high background signal,
MitoC and Cipro were used for further experiments. Further, LB and DMEM gave low
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background response, which were then used as re-suspension media to evaluate cytotoxicity
profile of STEC positive and STEC negative samples after a 3 h pre-induction with MitoC (2
μg/ml) and Cipro (100 ng/ml) at 37ºC with shaking at 120 rpm. All samples were analyzed for
LDH release after 16 h as described above. Visual examination of treated Vero cells under light
microscopy was captured at 400X magnification.
2.3.6

Growth of STEC in different enrichment broths

Shiga-toxin producing Escherichia coli EDL933 O157:H7 (~105 CFU/ml) were grown in
LB, DMEM, and mTSB (5 ml) at 37ºC or 42ºC with shaking at 120 rpm, and growth was
monitored by measuring the optical density (OD600 nm) every 2 h for 12 h and then again at 24
h using a spectrophotometer. Bacterial cell suspensions were diluted in PBS and plated on
SMAC to determine cell density at each time point.
2.3.7

Evaluation of cytotoxicity response from 2D and 3D Vero cells

A total of 27 bacterial isolates were screened for cytotoxicity potential after a 15 h
enrichment in mTSB at 42°C with shaking. Lipopolysaccharide from E. coli K-235 (3 endotoxin
unit/ml; Sigma, St. Louis, MO, USA) was also tested to determine whether it is responsible for
LDH release. Vero cell monolayers and collagen encapsulated cells (3.2 ×104 cells/ml) were
washed with serum free DMEM before exposure to STEC or non-STEC bacteria (300 μl ≈ 108
CFU/ml). Total volume of wells were adjusted to 500 μl with serum free DMEM before
incubation at 37°C in 5% CO2. To determine the limit of detection of the assay, overnight
cultures of STEC 204P O157:H7 and non-STEC 489 O157:H12 were re-suspended in LB and
serial dilutions of bacterial preparations were added to Vero cells and incubated for 16 h at 37°C
in 5% CO2. To determine optimal detection time, Vero cells were exposed to STEC and nonSTEC isolates (108 CFU/ml) for 2 h, 6 h, and 16 h. Salmonella and Listeria spp., Citrobacter,
Hafnia, and Serratia spp. were also tested to investigate assay specificity. All samples were
centrifuged at 1800 x g for 3 min and assayed for LDH. LDH values were acquired from three
independent sets of experiments and analyzed in duplicates. After LDH analysis, cells were fixed
with formaldehyde (4%) before Trypan blue (4%, 1:2 dilution) staining for 3 min to capture Vero
cell morphology after treatments at 400X magnification.
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2.3.8

Application of CARD

CARD was used to screen and detect STEC from artificially contaminated ground beef
samples. Three brands of ground beef, purchased from local grocery stores, were artificially
inoculated with STEC O157:H7 strain 204P and E. coli O157:H12 strain 489 under aseptic
conditions. Samples were processed following the USDA and NACMCF guidelines for
screening STEC in ground beef samples (FSIS 2014; FSIS, 2015; Foods NACMCF, 2010). In
brief, ground beef samples (32 ± 3.2 g) were placed in sterile strainer bags (Seward, Islandia, NY)
inoculated with 100 μl of O157:H17 strain 204P (6.7 ×102 ± 2.1 ×102 CFU/ml) and O157:H12
strain 489 (7.4 ×102 ± 5.9 ×102 CFU/ml). Samples were then diluted with 97 ± 1.9 ml of mTSB
and hand massaged for 1 min to homogenize before incubating at 42ºC for 15 h with shaking at
120 rpm. To determine final cell density after enrichment, samples were serially diluted (1:10 in
PBS) and plated on Sorbitol McConkey Agar (SMAC), and incubated at 37ºC for 24 h. For
CARD analysis, 300 μl samples were centrifuged at 10,000 ×g for 3 min and resuspended in the
same volume with LB before exposure to Vero cells (3.2 ×104 cells) embedded (2D or 3D??) in a
48 well plate format. After incubation at 37ºC for 6 h in 5% CO2, samples were centrifuged at
1800 ×g for 3 min and analyzed for LDH release. Uninoculated meat samples were also tested as
negative controls to check for background response and interference. Suspected colonies
identified on the SMAC were confirmed by PCR, targeting stx1 and stx2 genes.
2.3.9

DNA extraction and multiplex PCR

DNA templates were extracted following a boiling and colony PCR method (FDA, 2017;
Hoang, 2015). Stx-specific primers targeting stx1 (5′-ATCCTATTCCCGGGAGTTTACG-3′ and
5′- GCGTCATCGTATACACAGGAGC -3′) and stx2 (5′-CACCAGACAATGTAACCGCTG-3′
and 5′ TIACCATTTCAGTACCTTCTGGTAA-3′) genes were used to validate pure cultures and
CARD-identified STEC positive samples. DNA template from non-STEC isolates, uninoculated
meat samples, and water were used as negative controls. The reaction mixture (25 μl) contained
200 ng of DNA template, 1× GoTaq Flexi buffer, 1 U of GoTaq, 2.5 mM MgCl2, 200 µM
deoxynucleoside triphosphates (dNTP), and 4 µM of stx1 and stx2 forward and reverse primers.
The PCR was carried out with an initial denaturation step at 94°C for 120 sec, followed by 35
cycles of denaturation at 95°C for 60 sec, annealing at 57°C for 60 sec, 72°C for 60 sec and final
extension at 72 °C for 35 sec.
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2.3.10 Statistical Analysis
GraphPad Prism (version 6) software was used to perform ordinary one-way or two-way
ANOVA followed by Tukey’s multiple comparisons analysis to evaluate whether there is a
significant difference among media (LB, DMEM, EC, mTSB) and antibiotics (mitomycin C and
ciprofloxacin) during the selection of a suitable sample preparation to build CARD. SAS
software was used to perform 2x2x3 ANOVA followed by Tukey’s post hoc analysis to assess
interaction between isolates (+/- STEC), dimension, (2D v. 3D), and time (2 h, 6 h, and 16 h).

2.4

Results

Optimal Vero cell number was determined to obtain the highest cytotoxicity response and
to standardize the assay. The data presented in Figure 2.1A suggests that a seeding cell number
of 3.2 ×104 and 6.4 ×104 cells/well would ensure LDH signal within a linear range. LDH values
from these two Vero cell numbers were similar to published literature with an absorbance value
less than or equal to 1. However, an optimal seeding Vero cell number needed to show a strong
positive response was determined to be 3.2 × 104 cells. Vero cells seeded at 3.2 × 104 cells/well,
as oppose to a higher seeding density of 6.4 × 104 cells/well, yielded a higher cytotoxicity
response (89 ± 3%) after exposure to STEC O157:H7 strain 204P for 16 h (Figure 2.1B).
Furthermore, LDH opposed to the ALP found to be the most suitable biomarker for cytotoxicity
analysis in Vero cells. LDH release was 7 fold higher than ALP release (Figure 2.1C).
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Figure 2.1 Optimization of Vero cell assay.
(A) Graph of Vero cell seeding number versus LDH activity after treatment with 2% Triton X100 (black square) or DMEM (blue triangle) for 45 min. (B) Cytotoxicity response from Vero
cell seeding density of 3 × 104 cells/well and 6.4 × 104 cells/well after treatment with STEC 204P
O157:H7 and non-pathogenic E. coli 489 O157:H12 for 16 h. (C) Evaluation of LDH and ALP
release from Vero cell at seeding density of 3 x 104 cells/well after treatment with 2% Triton X100 for 45 min.
To find a suitable cell suspension medium and an antibiotic for improving Vero cellbased cytotoxicity response, we used four different growth media (LB, mTSB, EC, and DMEM)
and three antibiotics (mitomycin C, ciprofloxacin, and polymyxin B). LB and DMEM alone did
not have a negative effect on Vero cells, achieving low percent cytotoxicity ranging from 0-3 ± 2%
cytotoxicity (Figure 2.2A). On the other hand, high cytotoxicity was observed after treatment of
Vero cells with mTSB (69 ± 5% cytotoxicity) or EC (54 ± 4% cytotoxicity) alone and was
significantly higher than LB or DMEM alone (P < 0.05).
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Among the three antibiotics tested, Cipro and MitoC treatments produced low
background response (3 ± 1% cytotoxicity) and were significantly lower than PolyB treatment
(67 ± 2% cytotoxicity, P < 0.05) (Figure 2.2B). Antibiotics were also confirmed to have
antimicrobial activity as zone of inhibition was observed with increasing concentrations of
antibiotics used on a lawn of STEC O157:H7 strain EDL933 (Figure 2.3). Images of STEC
treated Vero cells after Trypan blue staining (4%, 1:2 dilution) support LDH cytotoxicity values.
Cell rounding, detachment, and a high number of cells that appeared blue due to Trypan blue
uptake were only observed in Vero cells treated with PolyB, EC, and mTSB (Figure 2.2A, Figure
2.2B). Interestingly, Vero cells exposed to overnight culture of non-STEC (~108 CFU/ml) in
mTSB gave significantly lower percent cytotoxicity (22 ± 2%, P < 0.05) as oppose to mTSB and
EC treatment separately. Nonetheless, background cytotoxicity from non-STEC bacteria
suspended in mTSB is still significantly higher (P < 0.5) than the LB and DMEM treatment
alone, which is also confirmed by microscopic examination of Vero cells with a moderate degree
of cytopathic effect after Trypan blue staining (Figure 2.2B).
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Figure 2.2 Effect of different media and antibiotics on Vero cell-based cytotoxicity assays.
Vero cells exposed to (A) bacterial growth media: DMEM, LB, EC broth, mTSB and (B)
antibiotics: ciprofloxacin, mitomycin C, and polymyxin B for 16 h. Treated Vero cells were
stained with Trypan blue (1:2) and visualized under microscope at 400X magnification. Vero cell
stained blue indicates the presence of cell membrane damage.
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Figure 2.3 Confirmation of antibiotic activity against STEC O157:H7 strain EDL933.
Growth of O157:H7 strain EDL933 after exposure to antibiotics. Lawn of culture (108 CFU/ml)
was incubated overnight at 37°C on BHI with different concentrations of ciprofloxacin,
mitomycin C, and polymyxin B. Zone of inhibition and cell lysis were captured using Bio-Rad
ChemiDoc imager.

Growth curves were generated to determine important information on bacterial growth
phase and physiological state of bacteria in the growth media. STEC O157:H7 strain EDL933
grown in mTSB, DMEM, and LB revealed different onsets of stationary phase (Figure 2.4A).
Exponential phase ended after 6 h of incubation in LB, 8 h in DMEM, and 12 h in mTSB. Plate
counts to measure cell density at each time point were in agreement with OD600 nm
measurements (Figure 2.4B). Stationary phase was observed after 6 h in LB, 8 h in DMEM, and
10 h in mTSB.
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Figure 2.4 STEC growth in different media.
(A) Growth curves based on optical density (OD) and (B) cell counts of E. coli O157:H7
EDL933 in modified tryptic soy broth (mTSB), Luria Bertani broth (LB), and Dulbecco’s
modified eagle medium (DMEM). Data are from 3 experiments.

Since DMEM resuspended cultures (~108) did not achieve any positive signals, LB was
selected as resuspension media for further experiments (Figure 2.5). No significant difference
was observed between treatments with antibiotic pre-induced STEC bacteria and uninduced
bacteria (P < 0.05) (Figure 2.6A). For instance, a 3 h-preinduction with MitoC (2 μg/ml) yielded
65 ± 4% cytotoxicity and 81 ± 8% cytotoxicity from Vero cells in response to O157:H7 strains
EDL933 and 204P, respectively. A similar trend was observed with a 3 h-preinduction with
Ciprofloxacin, achieving 60 ± 11% cytotoxicity in response to EDL933 and 71 ± 15%
cytotoxicity in response to 204P. For uninduced bacteria, exposure to the same isolates had
cytotoxicity values of 62 ± 9% for EDL933 and 76 ± 7% for 204P. All non-pathogenic E. coli
isolates did not show any significant difference among each other, but the cytotoxicity values
were significantly lower than STEC positive bacteria (P < 0.05), with cytotoxicity percentages
ranging from 3-7 ± 2%. Images of Vero cells stained with Trypan blue after treatment with a
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positive STEC and negative STEC isolate were in agreement with LDH based cytotoxicity
values, indicating the loss of intact membrane occurred only from Vero cells exposed to STEC
bacteria (Figure 2.6B).

Percent Cytotoxicity ± SD

100
80

204P O157:H7(Stx1/2+)
EDL933 O157:H7(Stx1/2+)
489 O157:H12 (Stx-)
490 O157:H19 (Stx-)

c
b

60
40

a

20
0

DMEM

LB

Figure 2.5 Effect of growth media, DMEM and LB on cytotoxicity of STEC. Cytotoxicity assay
of Vero cells exposed to STEC and non-pathogenic E. coli for 16 h. Overnight cultures were
centrifuged and re-suspended in DMEM or LB to evaluate its impact on cytotoxicity response
against STEC.
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Figure 2.6 Effect of antibiotic pre-induced STEC bacteria on cytotoxicity.
(A) Cytotoxicity assay of STEC and non-pathogenic E. coli pre-induced with antibiotics for 3 h
before exposure to Vero cells for 16 h at 37°C in 5% CO2. (B) Visual examination of Vero cell
morphology after treatment with E. coli strain 489 and STEC isolate 204P at 400X magnification.

2D and 3D Vero cell-assay can detect up to 107 CFU/ml after a 16 h exposure to STEC
(Figure 2.7A, Figure 2.7B). In Figure 2.7C, cytotoxic response from the 3D platform (38 ± 7%,
P < 0.05) was significantly higher than the 2D platform (26 ± 2%) after exposure to 107 CFU/ml
of STEC. Exposure to a higher concentration of STEC (108 CFU/ml), however, induced similar
level of cytotoxic response (72 ± 2 vs. 76 ± 4%). Cytotoxicity values of all non-STEC cultures
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tested in either 2D or 3D platform were significantly lower than the STEC bacteria (P < 0.05)
and the cytotoxicity values were negligible (0-5 ± 1%). Trypan blue stained Vero cell images
cytotoxicity data (Figure 2.7D). An increase in the concentration of STEC exposure resulted in
an increase of Trypan blue uptake and cell rounding.
A total of 27 isolates were used to validate CARD. Cytotoxic profile of each isolate is
presented in Table 2.2. To determine optimal time of detection, cytotoxicity values from 27
isolates were pooled together and divided into two groups (STEC or non-STEC). ANOVA and
Tukey’s post hoc analysis revealed that a significant interaction of STEC strains with Vero cells
in 2D and 3D configuration over time (Figure 2.8A). Responses from a 2D platform were
significantly lower than 3D platform at 6 and 16 h (P < 0.05). In 2 h, cytotoxicity response
against all isolates was low and no significant differences were observed between platforms.
Although a high percent cytotoxicity was achieved in 16 h on a 3D platform, a clear
differentiation between STEC and non-STEC can still be observed in 6 h on a 3D platform.
Since no significant difference was observed among negative controls at each time point on a 2D
or 3D format (P < 0.05), a cutoff value was determined by taking 3 standard deviations above the
mean of all negative controls (Table 2.3) and the assay threshold is established to be 15%
(Moodie et al. 2010), (Zhang et al. 1999). Vero cell images captured after infection with a STEC
positive and STEC negative isolates were in agreement with the cytotoxicity data (Figure 2.8B).
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Figure 2.7 Analysis of sensitivity of CARD.
Analysis of cytotoxicity of O157:H7 strain 204P and O157:H12 strain 489 in (A) 2D-CARD and
(B) 3D-CARD. (C) Effect of dimension (2D v. 3D) on the sensitivity of the assay. (D) Vero cells
treated with increasing concentration of STEC bacteria or non-pathogenic E. coli for 16 h and the
microscopic images captured under 400X magnification.
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Figure 2.8 Optimal time of detection using 2D and 3D-CARD system.
(A) Cytotoxicity profile of 2D and 3D Vero cells to 17 STEC isolates and 10 non-STEC isolates
over time. (B) Visual examination of Vero cells treated with STEC 204P O157:H7 and 489
O157:H12 for 2 h, 6 h, or 16 h at 400X after Trypan blue staining (1:2).

After treatment with Salmonella Tennessee, Salmonella Heidelberg, Salmonella Kentucky,
Listeria innocua F4248, Listeria monocytogenes F4244, Citrobacter freundii, Serratia
marcescens, Hafnia alvei, and non-pathogenic E. coli isolates, it has been confirmed that CARD
can specifically detect STEC among these non-STEC isolates (Figure 2.9A). These isolates were
presumptively identified after growing them on MOX, XLT4, SMAC, and REB (Figure 2.9B).
After trypan blue staining of treated Vero cells, only STEC associated damage was observed
(Figure 2.10).
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Figure 2.9 Specificity of CARD.
The assay shows (A) specificity of CARD toward STEC after 6 h of incubation. (B) Bacterial
cultures were presumptively identified using selective media Remel™ Modified Oxford Agar
(MOX), Xylose-Lysine-Tergitol 4 (XLT4), MacConkey Agar with Sorbitol (SMAC), and
RAPID'Enterobacteriaceae Agar (REB).
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Figure 2.10 Cytopathic effects of non-STEC and STEC strains on 3D Vero cells after Trypan
blue staining.
In Vero cells, STEC strain EDL933 caused severe cell damage, cell rounding, and cell death as
indicated by Trypan blue uptake. No damage was observed after a 6 h exposure to Salmonella
Tennesee, Listeria monocytogenes, Serratia marcescens, Citrobacter freundii, Hafnia alvei, and
Escherichia.

Table 2.2 Cytotoxicity of all bacterial strains used in this study to validate CARD
Cytotoxicity (Abs490/680)b
Culture

Isolate and Serotype

a

2h
2D (%)

6h

16 h

3D (%)

2D (%)

3D (%)

0.05±0.02
(0%)
0.72±0.19
(100%)
0.06±0.002
(0%)
0.07±0.01
(2%)
0.07±0.02
(2%)
0.08±0.02
(4%)
0.07±0.01
(2%)
0.07±0.03
(2%)
0.08±0.02
(4%)
0.08±0.02
(4%)
0.10±0.03
(7%)
0.17±0.03
(17%)
0.17±0.03
(15%)
0.15±0.01
(4%)
0.06±0.001
(1%)

0.05±0.02
(0%)
0.69±0.05
(100%)
0.11±0.02
(10%)
0.12±0.05
(12%)
0.26±0.01
(33%)
0.24±0.02
(30%)
0.45±0.01
(62%)
0.32±0.06
(43%)
0.38±0.04
(51%)
0.50±0.10
(69%)
0.37±0.02
(49%)
0.31±0.03
(41%)
0.26±0.01
(32%)
0.31±0.03
(41%)
0.50±0.06
(70%)

0.05±0.02
(0%)
0.69±0.21
(100%)
0.09±0.01
(7%)
0.13±0.04
(13%)
0.44±0.01
(61%)
0.45±0.08
(62%)
0.54±0.09
(76%)
0.26±0.01
(33%)
0.39±0.09
(53%)
0.56±0.04
(79%)
0.54±0.09
(77%)
0.43±0.02
(60%)
0.30±0.01
(39%)
0.42±0.04
(57%)
0.45±0.07
(63%)

2D (%)

3D (%)

48-well plate assay
Low control (DMEM+LB)
High control (2% Triton X-100)
E. coli

489 O157:H12
490 O157:H19
467 O5:NM
HSC7 O111:H8
SJ3 O26:H11
SEA13A72 O157:H7
488 O157:NM
HSC23 O91:H21
505B O157:H7
204P O157:H7
EDL933 O157:H7
HSC27 O111:H8
HSC16 OR:H7

0.04±0.01
(0%)
0.74±0.11
(100%)
0.09±0.01
(7%)
0.08±0.01
(6%)
0.09±0.01
(7%)
0.07±0.01
(4%)
0.09±0.004
(7%)
0.09±0.01
(7%)
0.15±0.03
(15%)
0.15±0.03
(15%)
0.07±0.05
(4%)
0.19±0.03
(20%)
0.06±0.07
(3%)
0.13±0.07
(13%)
0.08±0.01
(5%)

0.05±0.01
(0%)
0.71±0.04
(100%)
0.09±0.02
(6%)
0.06±0.004
(2%)
0.49±0.03
(67%)
0.22±0.06
(26%)
0.58±0.01
(80%)
0.29±0.01
(37%)
0.36±0.01
(47%)
0.50±0.02
(68%)
0.57±0.01
(79%)
0.52±0.01
(72%)
0.46±0.03
(62%)
0.35±0.01
(46%)
0.45±0.01
(60%)

0.05±0.01
(0%)
0.73±0.08
(100%)
0.07±0.01
(3%)
0.11±0.004
(9%)
0.56±0.03
(75%)
0.54±0.06
(72%)
0.68±0.01
(92%)
0.56±0.01
(75%)
0.40±0.01
(52%)
0.60±0.02
(81%)
0.63±0.01
(85%)
0.57±0.01
(76%)
0.50±0.03
(66%)
0.62±0.01
(84%)
0.55±0.01
(73%)
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Table 2.2 continued
SJ12 O103:H11
SJ9 O45:H2
SJ18 O121:H19
SJ23 O145:NM
Salmonella

Heidelberg 13ENT512
Kentucky
Tennessee

Listeria monocytogenes

F4244

Listeria innocua

F4248

Citrobacter freundii

43864
8090

Serratia marcescens

8100
43862

Hafnia alvei
a

18066

0.10±0.004
(9%)
0.09±0.003
(7%)
0.11±0.01
(9%)
0.04±0.002
(0%)
0.05±0.01
(2%)
0.05±0.002
(1%)
0.05±0.002
(1%)
0.06±0.01
(3%)
0.04±0.001
(0%)
0.07±0.02
(3%)
0.08±0.01
(5%)
0.06±0.001
(3%)
0.07±0.01
(3%)
0.06±0.001
(2%)

0.08±0.002
(3%)
0.09±0.003
(6%)
0.07±0.02
(2%)
0.07±0.16
(0%)
0.06±0.02
(1%)
0.06±0.002
(1%)
0.05±0.01
(0%)
0.05±0.02
(0%)
0.06±0.003
(0%)
0.05±0.002
(0%)
0.06±0.01
(1%)
0.09±0.03
(6%)
0.07±0.03
(3%)
0.06±0.003
(1%)

0.29±0.02
(37%)
0.30±0.01
(38%)
0.37±0.02
(50%)
0.23±0.01
(28%)
0.05±0.01
(1%)
0.05±0.01
(1%)
0.06±0.001
(2%)
0.04±0.01
(0%)
0.10±0.03
(8%)
0.05±0.002
(0%)
0.05±0.003
(0%)
0.11±0.08
(10%)
0.13±0.10
(13%)
0.05±0.004
(0%)

0.43±0.04
(59%)
0.46±0.07
(64%)
0.45±0.01
(62%)
0.33±0.04
(44%)
0.05±0.002
(1%)
0.07±0.01
(3%)
0.06±0.01
(2%)
0.05±0.001
(1%)
0.05±0.01
(0%)
0.06±0.03
(2%)
0.06±0.01
(2%)
0.07±0.03
(4%)
0.07±0.03
(3%)
0.05±0.01
(1%)

0.47±0.02
(63%)
0.48±0.04
(66%)
0.55±0.02
(76%)
0.36±0.01
(47%)
0.07±0.001
(2%)
0.10±0.004
(7%)
0.09±0.001
(6%)
0.13±0.002
(12%)
0.13±0.002
(11%)
0.08±0.002
(5%)
0.07±0.003
(3%)
0.09±0.08
(7%)
0.08±0.10
(4%)
0.09±0.004
(7%)

0.67±0.02
(91%)
0.58±0.04
(78%)
0.64±0.02
(86%)
0.54±0.01
(72%)
0.07±0.001
(2%)
0.07±0.004
(3%)
0.05±0.001
(0%)
0.09±0.002
(5%)
0.08±0.002
(5%)
0.09±0.03
(6%)
0.10±0.01
(7%)
0.06±0.03
(1%)
0.08±0.03
(4%)
0.09±0.01
(6%)

Cultures were obtained as previously described in Table 2

b

Percent cytotoxicity was calculated using formula: [(AExp-ALB control)/(ATriton X-ALB control)]x100 based on amount of LDH released from negative control, positive control, and
experimental samples; percent cytotoxicity are an average of three experiments displayed as means (±SD)
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Table 2.3 Determination of cutoff value using average of cytotoxic response from non-STEC bacteria
Cell Culture Platform

Platform

2D

3D

2h

6h

16 h

0.0910

0.109

0.091

0.0830

0.122

0.063

0.0533

0.052

0.066

0.0497

0.051

0.099

0.0493

0.060

0.090

0.0627

0.042

0.128

0.0407

0.100

0.125

0.0560

0.092

0.069

0.0677

0.133

0.114

0.0590

0.051

0.067

0.0570

0.067

0.072

0.0520

0.057

0.052

0.0527

0.052

0.087

0.0557

0.049

0.083

0.58

0.76

0.19

t-test

Average

0.07

Standard deviation

0.03

Cutoff value

0.15

Cutoff % cytotoxicity

15
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3D CARD system successfully detected STEC 204P O157:H7 in artificially
contaminated ground beef samples with cytotoxicity values above the 15% cutoff ranging from
36 - 61% (Figure 2.11A, Table 2.4). Non-STEC O157:H12 strain 489 served as negative control
for the assay and yielded low cytotoxicity values ranging from 3 - 7%, which was significantly
lower than STEC positive samples (P < 0.05). Cultures were further confirmed using SMAC,
Trypan blue staining of Vero cells, and multiplex PCR (Figure 2.11B, Figure 2.11C). Only
STEC positive samples had stx1 and stx2 genes and isolates are sorbitol negative on SMAC
plates. Cell rounding and Trypan blue uptake was observed in infected Vero cells with 204P
O157:H7.
To determine whether other virulence factors could be responsible for LDH release, 2D
Vero cells were exposed to LPS, hemolysin positive STEC strain B1409-C1, or hemolysin
negative STEC strain B1409 C1P at 37°C for 16 h with 5% CO2 (Figure 2.12). LPS induced low
cytotoxicity (0 ± 0.39%), showing no significant difference (P < 0.05) to the PBS treated 2D
Vero cells used as the control. Similar levels of LDH release was also observed when comparing
cytotoxicity values after 2D Vero cell exposure to hemolysin positive STEC strain B1409-C1 (52
± 1.9%) with hemolysin negative STEC strain B1409 C1P (52 ± 3.3%). Uptake of Trypan blue
and major changes in cellular morphology was not observed in LPS treated 2D Vero cells as
compared to hemolysin positive and hemolysin negative STEC strain.
STEC bacteria were selected as analyte of detection for 3D CARD due to simple sample
preparation outlined in Figure 2.13. As oppose to a 24 h Stx enrichment, STEC sample
preparation only requires the resuspension of overnight cultures (15 h) in LB and before
detection with 3D CARD in 6 h.
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Figure 2.11 Detection of STEC from inoculated ground beef samples using 3D-CARD.
(A) Percent cytotoxicity of STEC from inoculated ground beef samples (n=27) using 3D-CARD.
(B) Trypan blue staining of treated Vero cells show cell rounding and membrane damage after
exposure to ground beef spiked with STEC. SMAC plating presumptively identified the presence
of STEC. (C) Multiplex PCR gel showing the amplification of stx1 (348 bp) and stx2 genes (587
bp) from inoculated ground beef samples.
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Table 2.4 CARD screening and PCR confirmation of samples from artificially inoculated ground beef after 6 h
Ground beef a

Sorbitol
fermentation on
SMAC e

Percent Cytotoxicity b

Abs(490/680)

%

Multiplex PCR
(stx1 and stx2 gene) f
Boiling
method

colony
PCR

Sample 1
O157:H7 c

0.341±0.138

46

-

-

-

0.064±0.062

3

+

+

+

O157:H7

0.438±0.004

61

-

-

-

O157:H12

0.059±0.007

2

+

+

+

O157:H7

0.289±0.001

38

-

-

-

O157:H12

0.094±0.086

7

+

+

+

O157:H12

d

Sample 2

Sample 3

a

Three brands of ground beef procured from local grocery stores

b

Percent cytotoxicity was calculated using formula: [(AExp-ALB control)/(ATriton X-ALB control)]x100 from Table S.1 based
on amount of LDH released from negative control, positive control, and experimental samples; percent cytotoxicity
are an average of three experiments displayed as means (± SD)

c

Isolate 204P used as Stx positive control, carries both stx1 and stx2 gene

d

Isolate 489 as Stx negative control

e

+, colonies that can ferment sorbitol will appear pink on MacConkey agar with sorbitol (SMAC); -, colorless
colonies

f
DNA was extracted using boiling method directly and colony PCR from enrichment broth with food sample or
isolated colonies after plating on SMAC, respectively. stx1 and stx2 genes based multiplex PCR was performed with
initial denaturation at 95°C for 2 min, denaturation at 95°C for 1 min, annealing at 57°C for 1 min, and elongation at
72°C for 35 seconds
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Figure 2.12 Vero cell response to LPS, hemolysin positive and hemolysin negative STEC
isolates.
Cytotoxicity response of Vero cells after exposure to LPS, hemolysin-positive (B1409-C1) or
hemolysin-negative (B1409 C1P) STEC isolates. Treated Vero cells were stained with Trypan
blue (1:2) and captured at 400X magnification.
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Figure 2.13 Schematic showing sample preparation and bacteria or toxin detection strategy using
CARD system.
Duration of each step starting from the procurement of food sample (i.e. ground beef) is outlined
with the endpoint of the LDH cytotoxicity assay as indication of the presence of viable STEC or
functionally active crude Stx.
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2.5

Discussion

This is the first study demonstrating the application of Cell-based Assay for Rapid highthroughput Detection (CARD) of Shiga-toxin producing E. coli to detect and differentiate STEC
isolates from non-STEC isolates in food samples. Initially, CARD was modified and validated
with pure cultures. From the four bacterial growth media tested (LB, mTSB, EC), LB in
combination with DMEM provided the best result for detection. Although mTSB is the FSIS
recommended enrichment broth for STEC detection from food (USDA 2014; 2015), mTSB
seems to have a negative effect on Vero cells, making it an unsuitable medium to use with
CARD. mTSB and EC contain bile salt, which has been reported to have a potential cytotoxic
effect on mammalian cells (Kandell and Bernstein 1991). DMEM was thought to be an
appropriate resuspension medium since it is the growth medium for mammalian cells. However,
DMEM resuspended STEC cultures produced negative cytotoxicity results and was in agreement
with the findings from a previous study (Roberts et al. 2001). There may be certain inhibitory
substances in DMEM that can affect STEC virulence properties; however, a clear mechanism has
not been defined. On the other hand, STEC positive samples resuspended in LB gave desirable
cytotoxicity results, and LB was selected as an optimal resuspension medium for all cytotoxicity
assays.
Antibiotics or phage induction methods are typically used to induce or release Stx from
STEC bacteria either to improve Stx yield for pathogenesis studies or to improve sensitivity for
detection assays (Griffin and Gemski 1983; Yee et al. 1993; Zhang et al. 2000; Laing et al. 2012).
As Stx production and release is tightly regulated by Stx prophages, activation of SOS response
gene, recA, must occur to express downstream stx1 and stx2 genes (Tyler et al. 2013). DNA
damaging agents such as MitoC and Cipro that inhibit DNA synthesis or topoisomerase I,
respectively, can induce bacterial SOS response and induce Stx production. MitoC, Cipro, and
PolyB were used at recommended concentrations (Roberts et al. 2001; Shimizu et al. 2003;
Aertsen et al. 2005b; Maldonado et al. 2005; Wang et al. 2016). After verifying the low
interference from MitoC (2 μg/ml) and Cipro (100 ng/ml) alone, we continued to assess their
effect on the sensitivity of the overall assay. Interestingly, Vero cells did not respond well to
polymyxin B (1 mg/ml), showing a high background response. Although this method of Stx
release usually does not interfere with other detection assays such as ELISA or Western blot, it
may not be compatible with cell-based assays. Scientists have previously confirmed its cytotoxic
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effect on mammalian cells, interacting with the cytoplasmic membrane while disrupting osmotic
homeostasis and promoting oxidative stress (Neiva et al. 2013); (Vattimo et al. 2016).
STEC pre-induced with MitoC and Cipro for 3 h, before exposure to Vero cells for 16 h
did not seem to improve sensitivity of Vero cells to STEC, which suggests that antibiotics may
not be necessary for the development of CARD. Antibiotics were added in early exponential
phase since phage virulence is most effective in producing and releasing Stx phage and Stx
protein (Drulis-Kawa et al. 2012). In addition, an increase of virulence gene expression of STEC
O157:H7 in mid-log exponential phase and a down-regulation of stx gene expression during
stationary phase was reported by Bergholtz and colleagues (Bergholz et al. 2007). Although it is
important and logical to produce and release high amounts of Stx, exposure to viable uninduced
STEC cells seems to be just as effective. Interaction between STEC cells and Vero cells simulate
the pathogenesis of STEC, allowing the expression and production of major virulence factors in
response to potential stress factors that may contribute to the strong cytotoxicity responses
observed (Schüller 2011; Tran et al. 2014; Licznerska et al. 2016). However, hemolysin or LPS
(3 endotoxin unit/ml) alone may not play a major role in Vero cell cytotoxicity (Figure 2.12)
(Roberts et al. 2001). Antibiotics can be expensive, has a short shelf life, and requires continuous
restock of resources, which may not be practical for industry use. Thus, STEC bacteria after
resuspension in LB, without antibiotic treatment, are sufficient to achieve a strong positive signal.
It is challenging to bypass an enrichment step during food testing as it ensures full
recovery and survival of STEC for detection without running the risk of generating false
negatives (Sharpe 2001; Vetter 2016). Although the detection limit of CARD is high, requiring at
least 107 CFU/ml, a 15-h enrichment in mTSB should be able to achieve 107-8 CFU/ml in the test
sample for reliable detection of STEC from food samples. This enrichment step for sample
preparation is required in other detection assays such as ELISA and PCR (Gould et al. 2009). It
is well documented that immunoassays and PCR have superior sensitivity in detecting STEC (10
CFU/ml) and Stx (1.08 - 1.56 pg/μl); however, there are also drawbacks in detection time,
sample and reagent preparation, and information provided about functional activity of Stx and
viability of STEC (Pimbley and Patel 1998; Cui et al. 2003; Banerjee et al. 2013; Amani et al.
2015; Zeng et al. 2016). Vero cell assay can also detect picogram quantities of Stx, however,
detection time must be extended to 24 - 72 h to acquire confirmatory results (Hughes et al. 1998;
Rasooly and Do 2010; Lentz et al. 2011). We verified that detection time plays a role in
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sensitivity of the assay using pure Stx1 (Toxin Technologies, Sarasota, FL) and Stx2 toxins (BEI
Resources, Manassas, VA). Additionally, Stx sample preparation with the lengthy isolation,
enrichment, and concentration methods makes it cumbersome to be used as an analyte of
detection (Figure 2.13).
To overcome the burden of sample and assay preparation with a faster sampling and
detection time, 3D CARD system has been validated with 27 isolates of pure cultures and ground
beef samples (n=27, 3 brands) for successful detection of viable STEC cells in 6 h. Lactate
dehydrogenase is a typical isoenzyme found in animals, so interference from ground beef
samples before inoculation with STEC or non-STEC cells must be calculated to correct LDH
values (Collins et al. 1991; Šalplachta and Nečas 2000). These controls must be included every
sampling time while using CARD. Salmonella, Listeria, Citrobacter, Serratia, Hafnia, and nonpathogenic Escherichia coli following a 15-h enrichment in mTSB did not yield positive
cytotoxicity results, confirming the specificity of CARD to detect STEC. Negative cytotoxicity
results from Listeria spp. were expected as no growth on MOX was observed after mTSB
enrichment. It is possible that bile salt from mTSB may have inhibited the growth of Listeria spp.
by inducing DNA damage in Gram-positive bacteria after alteration of cell membrane (King et al.
2003; Begley et al. 2005; Merritt and Donaldson 2009). Further, aerobic conditions at 42°C is
not an optimal growth conditions for Listeria spp. and by-products produced such as lactate may
inhibit growth in the presence of salt (Romick et al. 1996; Sutherland et al. 2003; Yates 2011).
3D cell culture system improved the response of CARD compared to a 2D platform, which was
previously confirmed using Ped-2E9 hybridoma cells to detect Listeria monocytogenes,
Listeriolysin O, and Bacillus enterotoxin (Banerjee et al. 2008). With a similar approach, Vero
cells were encapsulated in a collagen matrix (0.7 mg/ml) due to its biocompatibility in tissue
culture applications and similarity to physiological conditions of epithelial cells. Since the
diameter of Vero cells has been reported to be approximately 17 μm with optimal rat tail
collagen concentrations around 0.6 - 1.1 mg/ml, a concentration at 0.7 mg/ml of collagen was
selected (Forno 2013; Wolf et al. 2013). Despite the high detection limit, CARD in a 3D format
has its advantages in addition to the high cytotoxicity results generated as compared to 2D
format as observed in both 6 and 16 h (Fig. 2.8A). Collagen’s strong gelling properties can act as
a protective barrier to enhance viability of cells and eliminate risk of tampering if CARD is used
for field-deployment (Banerjee et al. 2008; Parenteau-Bareil et al. 2010). Overall, a 6 h 3D Vero
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cell-based assay is more competitive than the previously modified 2D Vero cell-based assay (1216 h), STEC immunoassays, and PCR.
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COMPARISON OF THP-1 AND VERO CELL
SENSITIVITY TO STEC AND SHIGA-LIKE TOXINS

3.1

Abstract

The most important virulence feature of STEC is the production of Shiga-like toxins (Stx). Although
the 3D-CARD using Vero cells can detect STEC in 6 h, the low sensitivity of the assay may not be
ideal as a competitive detection platform in a food testing facility. The goal of this study is to
compare undifferentiated THP-1 and Vero cell response under 2D and 3D conditions against viable
STEC and active Stx. Initially, lactate dehydrogenase (LDH) release from undifferentiated 2D

THP-1 cells (3.2 ×104) was validated with the cytotoxicity release assay following Triton-X 100
(2%) treatment. Then, the effect of STEC with or without antibiotics (mitomycin C, 2 μg/ml and
ciprofloxacin, 100 ng/ml) on cytotoxicity of 2D Vero and 2D undifferentiated THP-1 were
examined. Stx enrichment was performed using mitomycin C (μg/ml), Ciprofloxacin (100 ng/ml),
UV (1 min, 115V/68 Amps), and polymyxin B (1 mg/ml) treatment where Stx production was
further quantified by dot-immunoblot using anti-Stx antibodies. Next, both cell lines were grown
in 2D or 3D in a collagen gel matrix, which was further evaluated to determine the limit of
detection (LOD), and optimal assay time (2 - 16 h) required to obtain a positive response against
crude or purified toxin preparations. Finally, Stx induced damage was visualized using Trypan
blue staining and cryo-SEM. THP-1 cells used at concentrations of 3.2 ×104 cells/ml was positive
for LDH release, which makes it suitable for running cytotoxicity assay. After exposure to viable
STEC strain 204P and EDL933 for 16 h, 2D Vero cells induced high levels of cytotoxicity that was
significantly (P < 0.05) higher than 2D THP-1 cells. Among the phage induction methods used,
mitomycin C (2 μg/ml) was chosen as the best Stx2 enrichment due to its high yield (~3-fold)

while Ciprofloxacin treatment yielded high Stx1 but low Stx2. After 6 h, LOD for commercial Stx
on 3D Vero was 31.25 ng/ml, 2D THP-1 was 62.5 ng/ml, 3D THP-1 was 125 ng/ml, and 2D Vero
was 1000 ng/ml. After 16 h, LOD against commercial Stx on 3D Vero was 500 ng/ml, 2D THP-1
was 31.25 ng/ml, 3D THP-1 was 62.5 ng/ml, and 2D Vero was 1000 ng/ml. No significant difference
was observed after treatment with crude Stx preparation for 6 h, but at 16 h, 3D Vero cells induced
the highest cytotoxicity response. Trypan blue staining and Cryo-SEM confirmed the cytopathic
effects of Stx. 3D Vero cells remain to be a competitive model for CARD in detecting both viable

60
STEC and functionally active Stx. This is the first study comparing THP-1 and Vero cell response to
STEC and Stx using the LDH release assay.

3.2

Introduction

Escherichia coli, a Gram-negative rod-shaped bacterium, is typically non-pathogenic, but
can become opportunistic in causing infection in immunocompromised hosts (Farrokh et al. 2013;
Balière et al. 2016). Strains that are pathogenic such as Shiga-like toxin producing Escherichia
coli (STEC) are responsible for a high number of foodborne illnesses and product recalls. STEC
can produce two different types of Shiga-like toxins (Stx), Stx1 and/or Stx2, which can be
further subdivided into Stx1a, Stx1b, Stx1c, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stxf, and Stxg.
Much attention was given to serotype O157:H7 after the first outbreak of STEC was reported
from undercook hamburgers in 1982 (Rangel et al. 2005). Standardized methodology was
established to specifically detect the serotype O157:H7, but fails to detect non-O157 serotypes
(O26, O45, O103, O111, O121, O145), which was implicated to be responsible for most of the
foodborne outbreaks in the United States (Michael A. Grant 2011). Since immunoassays and
PCR cannot provide information on the functional activity and viability of Stx and STEC,
respectively, this study highlights the importance of improving the recently developed cell-based
assay, CARD, that can detect biological activity of STEC serotypes.
Stx is a AB5 toxin (holotoxin) with a molecular weight around 68 kDa (Kaper et al. 2004;
Melton-Celsa 2014). The B subunit allows Stx to bind to Stx receptors, Gb3 or Gb4 on the
surface of epithelial and endothelial cells while the A subunit inhibits protein synthesis by
cleaving an adenine base from the 28S rRNA of the ribosomal 60S subunit, which eventually
leads to cell death. Both THP-1 and Vero cells possess Gb3 or Gb4 that binds to Stx. After
binding to Gb3 or Gb4 receptors on host cells, Stx is endocytosed and transported to the Golgi
apparatus before cleavage of A1 subunit by furin to become active. Active Stx is transported to
the endoplasmic reticulum where the disulfide bond linking the StxA1 subunit with StxA2-B is
reduced (Kurmanova et al. 2007; Johannes and Römer 2010). This allows StxA1 to reach the
cytoplasm to inhibit protein synthesis, and induce apoptosis. Stx release from EHEC may depend
on cell lysis after lytic phage induction and Stx production (Schüller 2011). Stx in EHEC is
encoded by lambdoid prophages where Stx production is controlled by the activity of the
promoter, pR and cI repressor protein. Phage takes advantage of the bacterial SOS pathway in
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response to DNA damage to inactivate cI and become lytic. This allows the expression of
downstream genes for Stx production and release. Stx1 production and release is also dependent
upon iron concentration in the environment (Shimizu et al. 2009). DNA damaging agents such as
mitomycin C, ciprofloxacin, and UV light are typical phage induction methods used to increase
Stx yield for detection and EHEC pathogenesis studies. Thus, we investigated different Stx
enrichment strategies and selected an optimal phage induction method for crude Stx preparation
to compare cytotoxicity responses between Vero and THP-1 cells.
Vero cells are known to be highly sensitive to Stx, however, other cell lines are still yet to
be investigated and compared to Vero cells on its sensitivity to Stx. There are also cell lines that
are Stx resistant, hence unsuitable for CARD. O’Brien and Holmes (O'Brien and Holmes 1987)
reported that only certain cell lines are sensitive to Stx such as HeLa and Vero cells, whereas
Hep-2, WI-38, baby hamster kidney, Chinese hamster ovary, Y-1 adrenal, L, and human
melanoma cell lines are slightly resistant or highly resistant to Stx. Ramegowda and Tesh
(Ramegowda and Tesh 1996) studied the effects of purified Stx on human peripheral blood
monocytes, differentiated and undifferentiated human myelogenous leukemia cell lines THP-1
and U-937. Undifferentiated THP-1 cells were shown to be more sensitive to Stx while the
differentiated THP-1, U-937 and human peripheral blood monocytes were resistant to Stx. Cell
lines resistant to Stx either had low levels of Gb3 or reduced Gb3 expression after the addition of
differentiation agents (Obrig and Karpman 2012). Different cell types will have different
mechanisms in regulating Gb3 synthesis, internalization and intracellular transport of Stx. Levels
of proinflammatory cytokines produced such as tumor necrosis factor alpha (TNF-α) and
interleukin 1β (IL-1β) from different cell types in response to the toxin may also contribute to the
difference in sensitivity. Since many different Stx sensitive cell types reside in the kidney,
human glomerular podocytes, endothelial, mesangial cells, and extraglomerular cells can be
potential candidates to improve CARD response.
While THP-1 sensitivity to Stx has been well documented in cell apoptosis studies, it has
not been used in cell death assays as a potential detection strategy against STEC cells and Stx
protein. Cameron and colleagues (2003) used flow cytometry and apoptosis biomarker,
phycoerythrin (PE)-conjugated Annexin V, and cell death indicator, 7-aminoactinomycin D (7AAD), to assess and quantify apoptosis (Cameron et al. 2003). A similar approach using
Annexin V-FLUOS and propidium iodide (PI) dyes for flow cytometry analysis of apoptosis in
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addition to DNA fragmentation, Western blot targeting BH3 interacting-domain death agonist
(BID) cleavage, cytochrome c release, and caspase activation, and caspase colorimetric assays
were performed to investigate apoptotic signaling pathways in undifferentiated THP-1 cells (Lee
et al. 2005). The same author then discovered the activation of ER stress response in monocytic
THP-1 cells after exposure to Stx and its contribution to apoptosis by performing ER Ca2+ release
assay using Fluo-5F acetoxymethyl ester AM, caspase assay, flow cytometry analysis using
Annexin V-FLUOS and PI, and Western blot targeting Bcl-2, caspase-8 and calpain (Lee et al.
2008). Since apoptosis can be detected in 4 h for infected THP-1 cells, THP-1 can potentially be
used to improve CARD and may have comparable or higher sensitivity than Vero cells. In this
study, we investigated a feasible method to prepare crude Stx and compared the sensitivity
between THP-1, and Vero cells grown in 2D or 3D format against Stx protein and viable STEC
cells. Validation of CARD with a different cell line can further assess the performance of the
previously designed platform where it may be applicable for industrial use to reduce future
occurrence of STEC associated foodborne outbreaks.

3.3
3.3.1

Materials and Methods

Cultures and growth conditions

E. coli isolates used in this study are displayed in Table 2.1. STEC isolates 204P
O157:H7, EDL933 O157:H7, 467 O5:NM, and SEA13A72 O157:H7 were used for crude Stx
preparation while non-pathogenic E. coli 489 O157:H12 was used as a negative control. For
bacterial culture preparations, cultures were grown in modified tryptone soy broth containing
0.15% bile salt, 0.4% dipotassium hydrogen phosphate, and 0.25% glucose (mTSB, Becton
Dickinson, Franklin Lakes, NJ) at 37°C for 15 h with shaking at 120 rpm. An aliquot of each
culture was centrifuged and re-suspended to a final volume of 300 μl in LB to reach a
concentration of 108 CFU/ml. Culture preparations were prepared fresh and used immediately for
all LDH-based cytotoxicity assays (Pierce Biotechnology, Rockford, IL). For confirmation
purposes, cultures were plated on Sorbitol McConkey Agar (SMAC, Becton Dickinson) and
subjected to colony multiplex-PCR targeting stx1 and stx2 genes following thermocycling
conditions as described in Chapter 2.
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3.3.2

Phage induction methods

Overnight cultures were diluted 1:50 in 50 ml LB and incubated for 3 h at 37°C with
shaking at 120 rpm before the addition of mitomycin C (MitoC, 2 μg/ml, Sigma, St. Louis, MO,
USA) or ciprofloxacin (Cipro, 100 μg/ml, Sigma). For UV light treatment, overnight cultures
were pelleted at 10,000×g for 3 min, re-suspended in LB, and dispensed into sterile petri dish.
Petri dish of cultures were placed 12 inches under UV lamp (115 V, 68 Amps, UVP, Upland, CA,
USA) for 1 min. All phage-induced cultures were further incubated for 5 h at 37°C with shaking
at 120 rpm before collecting supernatant after centrifugation at 10,000 ×g for 3 min. For
polymyxin B (PolyB, Sigma) treatment, 50 ml overnight culture was pelleted, re-suspended in
500 μl of PBS, supplemented with PolyB (1 mg/ml), and further incubated for 30 min before
collecting supernatant after centrifugation at 10,000×g for 3 min. Pellets from all treatments were
incubated with 100 μl of chloroform at room temperature for 30 min to improve Stx release and
Stx yield. Cell-free supernatants of all treatments were concentrated to about 3-5 ml (about 10
fold concentrated) using Amicon Ultra-15 Centrifugal Filter Units using a 50 kDa cut-off
cellulose membrane at 5000 ×g for 15 min (Millipore Sigma, Billerica, MA, USA).
3.3.3

Antibiotic and kill curves

Overnight cultures (~108 CFU/ml) were diluted 1:50 in 50 ml of LB (~106 CFU/ml),
incubated for 3 h at 37°C with shaking at 120 rpm before the addition of MitoC and Cipro and
further incubated for 5 h at 37°C. Optical density (OD600 nm) measurements and plate counts on
SMAC were taken to generate MitoC and Cipro curves every 3 h for 9 h and then again at 12 h
and 24 h. To generate UV kill curve, overnight cultures were re-suspended in LB and exposed to
UV light every 30 sec for 1 min and then again at 5 and 10 min. Plate counts on SMAC were
recorded at each time point.
3.3.4

Bicinchonic acid-based protein quantification

Total protein was quantified from crude Stx supernatants using Pierce BCA protein assay
kit (Thermo Scientific, Waltham, MA). Bovine serum albumin (BSA, Sigma, St. Louis, MO,
USA) was used to prepare a set of diluted standards with an initial concentration of 2 mg/ml to
generate a standard curve to quantify crude Stx. Standards and experimental samples (25 μl)
were added into 96-microtiter plates (Thermo Scientific) before the addition of working reagent
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(200 μl). Plates were covered and incubated at 37°C for 30 min before measuring absorbance at
562 nm using a microplate reader (BioTek, Winooski, VT). PolyB (2 mg/ml), MitoC (2 μg/ml),
and 10% glycerol can cause overestimation of total protein in samples. Cipro (100 ng/ml) did not
interfere with BCA assay. Background response from antibiotics and glycerol were subtracted
from experimental samples for accurate quantification of total protein.
3.3.5

Dot Blot Analysis

Nitrocellulose membranes (0.2 μm, Biotrace NT, Thermo Scientific, Rochester, NY,
USA) were prewetted in Tris-buffered saline with 0.1% tween 20 (TBST) for 1 min and placed
in Bio-Dot apparatus (Bio-Rad, Hercules, CA, USA). Screws were tightened under vacuum
before rehydrating membrane with 100 μl of TBST. Flow valve was adjusted to setting 2 where
apparatus is open to air and two-fold dilutions of crude toxin samples and Stx standards (Toxin
Technologies, Sarasota, FL, USA or BEI Resources, Manassas, VA, USA) were loaded into each
well. Samples were filtered through the membrane by gentle vacuum before washing sample
wells with 100 μl of TBST. After draining wash liquid by gentle vacuum, blots were transferred
to blocking solution (TBST with 5% non-fat dry milk) and incubated at room temperature for 45
min. After blocking, membranes were washed with TBST three times at room temperature for 3
min with gentle agitation. Primary antibody solution containing Stx1-1 or Stx2-5 (a gift from Dr.
Xiaohua He, USDA, Albany, CA, USA) at dilutions 1:1000 in TBST with 5% non-fat dry milk
was added to blots and allowed to incubate overnight at 4°C. Affinity of primary antibodies to its
binding partner were previously tested by the USDA scientists showing no cross reactivity and
were designed to recognize native Stx protein (Skinner et al. 2015), (Skinner et al. 2014), (Wang
et al. 2016). Western blots were also done to confirm that Stx1-1, not Stx2-5 antibodies, can be
used to recognize denatured Stx protein without cross-reactivity with Stx2 protein from standards
purchased from Toxin Technologies. After overnight incubation with primary antibodies, blots
were washed three times with TBST at room temperature for 3 min. Membranes were then
incubated with anti-mouse secondary antibodies conjugated with horseradish peroxidase diluted
1:1000 in TBST with 5% non-fat dry milk at room temperature for 2 h. Blots were washed three
times with TBST prior to chemiluminescence development using SignalFire ECL reagent (Cell
Signaling Technology, Danvers, MA) in Bio-Rad Molecular Imager ChemiDoc XRS (Bio-Rad,
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Hercules, CA). Image J software was used to estimate Stx protein from each treatment based on
pixel intensity of developed dot blots.
3.3.6

Cell culture

African green monkey kidney (Vero) cells and human monocytic cell line (THP-1) were
purchased from the American Type Culture Collections (ATCC, Manassas, VA) and maintained
in Dulbecco’s modified Eagles medium (DMEM, Sigma, St. Louis, MO, USA) and Roswell Park
Memorial Institute (RPMI, Sigma) with 10% fetal bovine serum, respectively. For all
cytotoxicity assays, 3.2 x 104 Vero or undifferentiated THP-1 cells were grown as monolayers or
suspensions, respectively, in 48 well plates at 37°C with 7% CO2 under humidity for 24 h. Cell
monolayers were trypsinized with 0.25% of trypsin (Sigma) as described in ATCC protocol and
cell counts were determined by Trypan blue (0.4%) staining (Sigma). Cell suspensions were
centrifuged and cell counts were determined by Trypan blue staining. For 3D cell culture, 3.2 x
104 Vero or undifferentiated THP-1 cells were embedded with collagen (0.7 mg/ml) in a 48 well
plate format and allowed to solidify at 37°C with 7% CO2 under humidity for 30 min before the
addition of DMEM or RPMI supplemented with 10% fetal bovine serum. Vero cells grown in
monolayer and THP-1 cells grown in suspension were referred to as 2D platform while
comparing cytotoxicity of analytes against cell lines embedded in 3D platform.
3.3.7

Cell Cytotoxicity Assay

Lactate dehydrogenase release was measured as described previously (Roberts et al. 2001;
Maldonado et al., 2005). THP-1 suspension cells were centrifuged (1800 ×g for 3 min), washed
with serum-free RPMI and seeded at 3.2 x 104 cells in 48 well plates with an initial volume
adjusted to 200 μl/well. Vero cell monolayers and Vero embedded cells were washed with
serum-free DMEM before the addition of DMEM (200 μl/well). Cells were exposed to 300 μl of
viable STEC cells (~108 CFU/ml) or serial dilutions of crude or commercial Stx1a, Stx2a, and
Stx2c toxins for 16 h. Time dependent measurements were also taken with commercial Stx
toxins at 2, 6, 16, and 24 h of incubation. Supernatants were collected and centrifuged at 10,000
×g for 3 m and the cell free supernatants (50 μl) were mixed with an equal volume of LDH
reaction mix (50 μl) to a sterile 96 flat bottom well plate. Plates were incubated for 15-20 min at
room temperature and measured for LDH release at absorbance (490/680) in a microplate reader
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(Epoch, BioTek, Winooski, VT, USA). Percent cytotoxicity of experimental samples was
calculated using cells treated with DMEM+LB as low controls, and 2% Triton X-100 as high
control. Crude toxin and viable cells from STEC O157:H7 strain 204P or commercial Stx toxins
were used as positive controls for all LDH assays while cell free supernatant or viable cells from
non-pathogenic Escherichia coli O157:H12 strain 489 were used as negative controls.
3.3.8

Cryo-SEM of Vero cells in 3D matrix

Minimally dehydrated collagen gel embedded Vero cells were mounted on slotted Gatan
holders with 1 mm of sample above the holder. Samples were cryo-transferred after plunge
freezing with nitrogen slush into the Gatan preperation chamber, which is held under high
vacuum. Frozen samples were fractured with a cold scalpel in the Gatan Alto 2500 preparation
chamber at -185ºC (Pleasanton, CA, USA) before being transferred into the SEM chamber.
Samples were mounted on the cryo stage set for -90ºC sublimation, and imaged until a structure
was observed before sputter coating for 120 sec using a platinum target at -185ºC. SEM cryo
stage was lowered to -140ºC during sputter coating and was reinserted onto the NovaNano SEM
cryo stage before capturing final images of fractured surfaces. An accelerating voltage of 5kv
and spot size 3 with a working distance of approximately 5 mm at magnifications ranging x 1000
and x 10,000 were used in the NovaNano SEM.
3.3.9

Statistical analysis

Values are presented as mean ± SD. GraphPad Prism (version 6) software was used to
perform ordinary one-way or two-way ANOVA followed by Tukey’s multiple comparisons
analysis to evaluate whether there is a significant difference among cell lines, dimension (2D vs
3D) and time of cytotoxicity analysis CARD. The same software including Image J was also
used to assess Stx yield among phage induction treatments and isolates (+/- STEC).

3.4

Results

LDH values were significantly higher than ALP values with a 3-fold difference (Figure
3.1A). No significant difference was observed between treatments with antibiotic pre-induced
STEC bacteria and uninduced bacteria (P < 0.05) except for EDL933 (Figure 3.1B). A 3 hpreinduction with MitoC (2 μg/ml) yielded 34 ± 7% cytotoxicity and 36 ± 3% cytotoxicity from
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THP-1 in response to O157:H7 strains EDL933 and 204P, respectively. A similar trend was
observed with a 3 h-preinduction with ciprofloxacin, achieving 32 ± 2% cytotoxicity in response
to 204P. This was not the case for EDL933 since MitC preinduction generated significantly
higher cytotoxicity response than Cipro preinduction. For uninduced bacteria, exposure to the
same isolates had cytotoxicity values of 12 ± 7% for EDL933 and 44 ± 0.4% for 204P. All nonpathogenic E. coli isolates did not show any significant difference among each other, but the
cytotoxicity values were significantly lower than STEC positive bacteria (P < 0.05), with
cytotoxicity percentages ranging from 0-3 ± 3%. When responses were compared between Vero
and THP-1 from uninduced and preinduced STEC, Vero generated significantly higher
cytotoxicity values than THP-1 (Figure 3.1C).
3D Vero cells induced the highest LDH release after exposure to commercial Stx2a (68%)
and Stx2c (83%) with similar cytotoxicity response with 2D THP-1 cells to Stx1a (55 - 58%)
(Figure 3.2A). On the other hand, 2D Vero and 3D THP-1 cells induced the lowest cytotoxicity
response ranging from 29 - 37%. No significant difference was observed for negative controls
(0-1%). Stx-induced damage was validated with Trypan blue (1:1) stained mammalian cells
where only cells treated with 1000 ng/ml of total protein from non-pathogenic E. coli O157:H12
strain 489 were colorless (Figure 3.2B). Mammalian cells treated with commercial Stx took up
Trypan blue. Interestingly, limit of detection varied among the cell lines showing 1000 ng/ml for
2D, 500 ng/ml for 3D Vero cells, 62.5 ng/ml for 3D THP-1 cells and 31.25 ng/ml for THP-1
cells in suspension (Figure 3.3). Limit of detection at 16 h was determined based on the lowest
signal achieved where commercial Stx variant 2a, 2c, and 1a can be differentiated or
significantly different from the negative control.

68

Figure 3.1 Comparison of cytotoxic response of STEC towards Vero and THP-1 cell lines.
Comparison of cytotoxicity response from THP-1 and Vero cells after confirmation that (A)
THP-1 contains higher amount of LDH than ALP before exposure to (B and C) mitomycin C (2
µg/ml) and ciprofloxacin (100 ng/ml) pre-induced STEC.
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Figure 3.2 Cytotoxicity response against functionally active commercial Stx. Cytotoxicity
response of (A) THP-1, 2D and 3D Vero cells to 1000 ng/ml of commercial Stx1a, Stx2a, and
Stx2c after 16 h and (B) cytopathic effects of each treatment (400X magnification after Trypan
blue staining).
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Figure 3.3 Limit of detection of active commercial Stx preparation against each cell line after 16
h.
Comparison of sensitivity against commercial Stx1a, Stx2a, Stx2c toxins with supernatant of
O157:H12 strain 489 as negative control in (A) 2D Vero cells, (B) 3D Vero cells, (C) 2D THP-1
cells, and (D) 3D THP-1 cells.
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As displayed in Figure 3.4, antibiotic and UV kill curves were generated to determine the
effectiveness of these treatments on induction of toxin production (Aertsen et al., 2005; Shimizu
et al., 2009, Thomas Walter, personal communication). Table 3.1 and 3.2 outlines the cell
density over time before and after MitC, Cipro, and UV treatment. For MitC and Cipro treatment,
overnight cultures were diluted 1:50 in LB and allowed to grow for 3 h at 37°C, reaching a cell
density of about 4 x 106 CFU/ml before the addition of antibiotics. Exponential growth ended
after 4 h, since the addition of MitC and Cipro, reached a cell density of about 3.5 x 107-8
CFU/ml. Bacterial cell lysis was observed as the OD reading dropped and the cell counts were
7.37 x 106 ± 5.31 x 105 and 6.87 x 107 ± 2.87 x 106 CFU/ml after 9 h, and about 2 x 106 CFU/ml
after 12 h. Interestingly, after 24 h, cells grew to 5.40 x 108 ± 7.26 x 107 and 7.50 x 108 ± 1.04 x
108 CFU/ml after Cipro and MitC treatment, respectively, which may be an indication of
bacterial resistance to antibiotics. For UV treatment, overnight cultures were pelleted and resuspended in the same volume of fresh LB before induction. With an initial cell density of 1.93 x
107 ± 1.07 x 107 CFU/ml, an immediate drop in OD and a one-log reduction (4.23 x 106 ± 1.82 x
106) was observed after 5 sec of UV treatment. A 10% of cell survival was achieved after 1 min,
reaching a cell density of 1.14 x 105 ± 1.26 x 105 CFU/ml.
Total protein quantified (Table 3.3 and Table 3.4) was used to standardize the dot blot
and cytotoxicity assays. Standard curves for Stx1 and Stx2 (Figure 3.5B, Figure 3.5C) were
generated based on dot blot analysis of two-fold dilutions of Stx1 and Stx2 standards (Figure
3.5A). The linear portion of Stx1 standard curve generated a linear equation of y = 0.0001649x0.0682 and Stx2 standard curve generated a power regression equation of y = 105x2.6699. Stx1 and
Stx2 standard curves were used to determine the best phage induction method for Stx enrichment
and Stx yield from STEC isolates. Standard curves for BSA, Stx1 and Stx2 were generated to
estimate total protein and crude Stx protein produced in the STEC supernatant after the phage
induction. BSA standard curve gave a linear plot (y=0.001069x+0.05491) to quantify total
protein (Figure 3.5D).
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Figure 3.4 Effect of Antibiotic and UV on bacterial viability.
Overnight cultures were grown in mTSB at 37°C for 15 h and were then diluted to 1:100 in LB
for phage induction treatment. For antibiotic treatments, OD was measured before and after the
addition of mitomycin C (2 µg/ml) or ciprofloxacin (100 ng/ml) every three hours for 24 hours.
For UV light treatment, cell density was measured using plate agar method on SMAC every 15
sec until 10% cell survival was achieved and further incubated at 37°C for 5 h to induce Stx
phage.

Table 3.1 Cell density of 204P O157:H7 after phage induction using antibiotics
Treatment

Cell Densityc

0
3h
5h
7h
9h
12 h
24 h
6
6
7
7
6
6
8
2.60×10
±
4.00×10
±
7.23×10
±
2.37×10
±
7.37×10
±
2.87×10
±
5.40×10
±
ciprofloxacina
5.10×105
3.74×105
1.58×107
4.64×106
5.31×105
5.31×105
7.26×107
3.10×106±1.
4.53×106±
2.27×107±
4.33×108±
6.87×107±
1.93×107±
7.50×108±
mitomycin Cb
6
5
6
7
6
6
10×10
4.92×10
5.44×10
6.94×10
2.87×10
4.78×10
1.04×108
a
ciprofloxacin (100 ng/ml) added to overnight cultures diluted 1:50 after 3 h incubation at 37°C before further incubation at
37°C for 5 h
b

mitomycin C (2 μg/ml) added to overnight cultures diluted 1:50 after 3 h incubation at 37°C before further incubation at 37°C
for 5 h

c

Untreated and treated STEC 204P O157:H7 plated on SMAC to enumerate bacterial cell density

Table 3.2 Cell density of 204P O157:H7 after phage induction using UV light
Treatment

Cell Densityb

0
5s
10 s
15 s
60 s
5m
10 m
1.93×107±
4.23×106 ±
1.71×106±
1.16×106±
1.14×105±
NG
NG
1.07×107
1.82×106
1.55×106
8.98×105
1.26×105
a
UV lamp was placed 12 inches away from samples and treated at 115V/68 Amps for 1 min before further incubation at 37°C for 5 h
UV lighta

b

Untreated and treated STEC 204P O157:H7 plated on SMAC to enumerate bacterial cell density

c

NG, No growth
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Dot blot of crude Stx or 500 μg/ml of total protein from each treatment is shown in
Figure 3.6A. MitoC treatment induced the highest Stx2 yield (3300 ± 0.30 ng/ml) from reference
isolate, STEC 204P O157:H7 only after concentrating the supernatant with a 50-kDa cut-off
membrane filter (Table 3.3). This was about 3000-fold higher than the control and
unconcentrated crude Stx from MitoC induced STEC 204P O157:H7.

UV light induced

comparable levels of concentrated Stx2 protein as MitoC with a max yield of 1687 ± 0.42 ng/ml,
which was about 1000-fold higher than the control and unconcentrated crude Stx from UV
induced STEC 204P O157:H7. Cipro and PolyB induced the lowest concentration of Stx2 with
314 ± 0.03 and 417 ± 0.06 ng/ml, respectively. This was 300 – 400-fold higher than the control
and unconcentrated crude Stx from Cipro and PolyB induced STEC 204P O157:H7. On the other
hand, Cipro treatment induced the highest Stx1 yield (1260 ± 12 ng/ml) while UV induced the
lowest amount Stx1 yield (316 ± 16 ng/ml) after a concentration step. MitoC induction released
906± 31 ng/ml of Stx1 while PolyB treatment released undetectable amounts of the same protein.
MitC treatment induced about 900-fold higher than the control. Dot Blot analysis indicated a
detection limit of 39 ng/ml for Stx1 and 19.5 ng/ml for Stx2. Stx concentrations calculated that
were below this threshold was considered undetectable.
In Figure 3.6B, Stx yield was visualized using dot blot analysis from different STEC
isolates after MitC induction. Non-pathogenic E. coli isolates 489 and 490 were used as negative
controls, and they did not produce Stx1 or Stx2 protein as expected. On the other hand, isolate
EDL933, SEA13A72, and 467 were able to express Stx1, Stx2, or both types of Stx protein
(Table 3.4). Isolate 204P produced the highest amount of Stx2 (3298 ± 0.30 ng/ml) while
EDL933 produced the highest amount of Stx1 (2502 ± 412 ng/ml). Both isolates also produced
Stx1 (906 ± 306 ng/ml) and Stx2 (1290 ± 0.34 ng/ml), respectively, as expected since they both
express stx1 and stx2 genes. Isolate 467 released 1586 ± 4.2 ng/ml of Stx1 and did not produce
Stx2 while isolate SEA13A72 produced 1898 ± 7.7 ng/ml of Stx2, but did not produce Stx1.
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Figure 3.5 Standard curves for BSA and Stx quantification.
Standard curves were generated to quantify total protein and Stx protein before and after dot blot
analysis. Two-fold serial dilutions of BSA, commercial Stx1 and Stx2 obtained from Toxin
Technologies (D), respectively, were used to establish (A) BSA, (B), Stx1, and (C) Stx2 standard
curves.
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Figure 3.6 Dot Blot analysis of isolated Stx from phage induced STEC cells.
Dot blot analysis of crude Stx1 and Stx2 protein (A) before and after concentration from 204P
O157:H7 5 h after induction with mitomycin C, ciprofloxacin, polymyxin B, and UV light and
(B) after concentration from EDL933 O157:H7, SEA13A72 O157:H7, 467 O5:NM, 489
O157:H12, and 490 O157:H19 5 h after treatment with mitomycin C.

Table 3.3 Stx yield from 204P O157:H7 5 h after induction with UV, mitomycin C, ciprofloxacin, or polymyxin B
Treatment

Volume
(ml)

Max. Stx yield

Max. Stx yield

Stx1

Stx2

Concentrated
(Total Protein ug/ml)

Stx1

Stx2

ND

ND

996±317

ND

ND

ND

ND

200

723±99
3814±82

3984±317

ND

2.75±0.01

UV

50

1010±119

ND

215±7.5

1533±42

316±475

1687±0.42

mitomycin C

50

1766±87
1826±35

72.7±32

81.3±0.12

1915±10

906±305

3298±0.30

852±7.5

10.66±0.01

2738±612
1260±12
ND
ND
3314±314
3540±0.108
ND
polymyxin B
200
a
UV lamp was placed 12 inches away from samples and treated at 115V/68 Amps for 1 m before further incubation at 37°C for 5 h

314±0.04

Control

ciprofloxacin

50

Unconcentrated
(Total Protein ug/ml)

50

b

mitomycin C (2 μg/ml) added to overnight cultures diluted 1:50 after 3 h incubation at 37°C before further incubation at 37°C for 5 h

c

ciprofloxacin (100 ng/ml) added to overnight cultures diluted 1:50 after 3 h incubation at 37°C before further incubation at 37°C for 5 h

d

polymyxin B (1 mg/ml) added to pellet from overnight culture and incubated for 30 m at 37°C

e

Total protein quantified using BSA curve, y=0.001069x+0.05491

f

ND, not detectable

417±0.06
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Table 3.4 Bacterial strains used in this study for Stx toxin preparation

E. coli isolate

Serotype

PCRa

Total Protein (ng)b

Max. Stx yield (ng/ml)

Uninduced

Induced

Stx1

Stx2

489

O157:H12

none

1999±90

1739±30

ND

ND

490

O157:H19

none

1484±89

1240±27

ND

ND

467

O5:NM

stx1

1429±21

1794±62

1586±4.2

ND

SEA13A72

O157:H7

stx2

1405±189

1627±55

ND

1898±7.7

204P

O157:H7

stx1/2

1000±75

1724±26

906±306

3298±0.30

EDL933

O157:H7

stx1/2

1040±42

1904±55

2502±412

1290±0.34

a

stx1 and stx2 gene based multiplex PCR was performed with initial denaturation at 95°C for 2 min, denaturation at
95°C for 1 min, annealing at 57°C for 1 min, and elongation at 72°C for 35 seconds

b

Total protein quantified using BSA standard curve, y=0.001069x+0.05491

2D Vero, 3D Vero, and 2D THP-1 cells induced high cytotoxicity responses from
concentrated crude Stx after MitoC and UV treatment (Figure 3.7). MitoC induced STEC and
cell-free concentrated preparations (3.2 fold) yielded 20 ± 1% cytotoxicity in 2D Vero, 68 ± 9%
cytotoxicity in 2D THP-1, and 82 ± 18% cytotoxicity in 3D Vero which was significantly higher
than the UV-induced samples where cytotoxicity values were 15 ± 3%, 51 ± 2%, and 77 ± 13%
for 2D Vero, 2D THP-1, and 3D Vero, respectively. Cell-free concentrated Stx preparations for
all treatments significantly increased the percent cytotoxicity as compared to unconcentrated Stx
for all cell lines. For instance, cell-free concentrated crude Stx from MitoC treatment induced 20
± 1% cytotoxicity in 2D Vero as compared to the unconcentrated crude Stx from the same
treatment (11 ± 3%) (Figure 3.7A). Similar trend was also seen in Figure 3.7B and 3.7C with
cell-free concentrated crude Stx from MitoC treatment showing a significant increase in percent
cytotoxicity (82 ± 18% for 3D Vero, 68 ± 9% for 2D THP-1, P < 0.05) as oppose to exposure of
unconcentrated crude Stx from the same treatment (34 ± 11% for 3D Vero, 19 ± 8% for 2D
THP-1). This was also the case for UV treated samples where a strong percent cytotoxicity was
achieved (15 ± 3% for 2D Vero, 51 ± 2% for 2D THP-1, 77 ± 13% for 3D Vero) when samples
were concentrated and cytotoxicity was significantly higher than the responses from
unconcentrated samples (7 ± 1% for 2D Vero, 22 ± 4% for 2D THP-1, 19 ± 7% for 3D Vero). As
expected, cytotoxicity data from culture filtrates after Cipro and PolyB treatment were in
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agreement with the dot blot data, showing low yield of Stx1 and Stx2 with low cytotoxicity
values (0 - 1.62%). Cytopathic effect of Trypan blue stained cells exposed to concentrated crude
Stx show good agreement with cytotoxicity data (Figure 3.8). Cells that did not take up Trypan
blue or had minimal uptake of Trypan blue were observed in crude Stx preparation from Cipro
and PolyB treatment and supernatant from non-pathogenic E. coli isolate 489.
In order to perform statistical analysis, data for commercial Stx activity (Stx 1 and Stx2)
was pooled together and compared with negative control over time (Figure 3.9A). Earliest
indication of cytotoxicity was at 2 h with 2D THP-1 cells where cytotoxicity response from a
commercial Stx (11 ± 5%) was significantly higher than the negative control (4 ± 0.1%). At 6 h,
comparable levels of percent cytotoxicity were observed between 2D THP-1 (39 ± 7%) and 3D
Vero (35 ± 0.4%), which was significantly higher than the 2D Vero (15 ± 3%). Interestingly, a
significant difference can be seen in 16 h where 3D Vero generated the highest cytotoxicity
response (70 ± 10%), which was significantly higher than with the 2D THP-1 (46 ± 8%) and 2D
Vero (35 ± 4%). By 24 h, 2D THP-1 and 3D Vero had comparable levels of cytotoxicity (84 89%) caused by the commercial Stx preparation, which was significantly higher than 2D Vero
(77 ± 3%). Supernatant from non-pathogenic E. coli used as the negative control induced low or
undetectable levels of cytotoxicity (0 - 3.5%). A different trend between time and percent
cytotoxicity was observed when using a crude Stx preparation from MitoC induced STEC 204P
O157:H7 (Figure 3.9B, Figure 3.9C). All cell lines had comparable levels of cytotoxicity
induced by crude Stx in 6 h where no significant difference was observed (31 - 51%). However,
in 16 h, percent cytotoxicity of 3D Vero cells (82 ± 18%) was significantly higher than 2D THP1 (68 ± 9%), 2D Vero cells (23 ± 2%) and 3D THP-1 cells (53 ± 7).
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Figure 3.7 Cytotoxicity response from different cell lines exposed to cell-free unconcentrated
and concentrated Stx preparations.
Cytotoxicity response from (A) 2D Vero, (B) 3D Vero, and (C) undifferentiated THP-1 cells
against crude Stx preparation from mitomycin C, ciprofloxacin, polymyxin B, or UV light
induced 204P O157:H7 before and after concentration using the Amicon Ultra-15 Centrifugal
Filter Unit with 50-kDa Ultracel-3 membrane. Two-fold serial dilutions of crude Stx before and
after concentration were added to Vero cells and incubated for 16 h at 37°C with 5% CO2.
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Figure 3.8 Visual examination of 2D Vero, 3D Vero, and 2D THP-1 cells after exposure to crude
Stx preparations.
Cells were stained with Trypan blue for 3 min and images (400X) were captured after 16 h post
infection with 500 µg/ml of crude Stx from MitoC, Cipro, PolyB, or UV induced 204P O157:H7
before and after concentration using Amicon Ultra-15 Centrifugal Filter Unit with 50 kDa
Ultracel-3 membrane.
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Figure 3.9 Effect of time and cell line on CARD response to commercial Stx and crude Stx
preparation from MitoC induced STEC 204P O157:H7.
Commercial Stx preparations were pooled together (A) to compare cytotoxicity response from
2D Vero, 3D Vero, 2D THP-1 cells against supernatant from non-pathogenic E. coli as the
negative control at 2, 6, 16, and 24 h. Cytotoxicity responses of 2D Vero, 3D Vero, 2D THP-1
and 3D THP-1 cells after exposure to crude Stx preparation from MitoC induced 204P O157:H7
were evaluated at (B) 6 h and (C) 16 h.
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The 6 h time point was determined to be the optimal detection time for crude Stx
preparation. This was based on the 12% cytotoxicity threshold established by taking three
standard deviations above the mean from the negative control (cells treated with supernatant
from non-pathogenic E. coli). A response below this threshold is considered negative for Stx. As
shown in Table 3.5, cell-free concentrated crude Stx from MitoC induced STEC isolates yielded
cytotoxicity responses that were significantly higher (12 - 47%, P < 0.05) than supernatant from
MitoC induced non-pathogenic E. coli isolates (0 - 8%). No significant difference (P < 0.05) was
observed among cell line and platform (2D vs 3D) after 6 h of exposure to crude Stx preparation
from different STEC isolates (12-54%).
Limit of detection for commercial Stx preparation was re-evaluated at 6 h, showing a
slight difference in sensitivity as compared to the 16 h data (Figure 3.10). 3D Vero and 2D THP1 cells can detect Stx up to 31.25 ng/ml, which was significantly lower than 2D Vero (1000
ng/ml) and 3D THP-1 cells (125 ng/ml). As mentioned previously, Stx1a for 3D THP-1 cells was
not tested.
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Figure 3.10 Re-evaluation of limit of detection at 6 h.
Comparison of sensitivity against commercial Stx1a, Stx2a, Stx2c toxins with supernatant of
O157:H12 strain 489 as negative control in (A) 2D Vero cells, (B) 3D Vero cells, (C) 2D THP-1
cells, and (D) 3D THP-1 cells. Note: Due to limitation of resource, Stx1a was not tested for 3D
THP-1 cells.

Table 3.5 Comparison of cytotoxicity response to concentrated crude Stx pre-induced with MitoC (2 μg/ml) after 6 h
Cytotoxicity (Abs490/680)b
E.coli Isolate and
Cell line

Serotypea
d

%

3D-THP-1

%

2D Vero

%

3D Vero

%

0.063±0.015

0

0.051±0.01

0

0.048±0.006

0

0.051±0.007

0

0.607±0.108

100

0.569±0.02

100

0.708±0.054

100

0.731±0.081

100

489 O157:H12

0.066±0.006

1

0.067±0.01

3

0.065±0.003

3

0.105±0.042

8

490 O157:H19

0.10±0.002

7

0.071±0.01

3

0.082±0.005

5

0.89±0.005

6

467 O5:NM

0.129±0.034

12

0.124±0.03

13

0.215±0.123

25

0.224±0.086

25

SEA13A72 O157:H7

0.239±0.001

32

0.191±0.07

27

0.182±0.003

20

0.236±0.018

27

204P O157:H7

0.334±0.034

50

0.263±0.02

41

0.254±0.030

31

0.401±0.035

51

EDL933 O157:H7

0.354±0.001

54

0.235±0.03

36

0.250±0.007

31

0.375±0.002

47

2D THP-1
48-well plate assay
Low control
c

(DMEM+LB )
High control
(2% Triton X-100)

a

Isolates obtained from our culture collection

b

Percent cytotoxicity was calculated using formula: [(AExp-ALB control)/(ATriton X-ALB control)]x100 based on amount of LDH released from negative control, positive

control, and experimental samples; percent cytotoxicity are an average of three experiments displayed as means (±SD)
c

LB, Luria-Bertani Broth

d

Undifferentiated THP-1 cells

85

86

The crude Stx induced damage of Vero cells embedded in a collagen matrix was
visualized using Cryo-SEM (Figure 3.11). Structural changes of the cell membrane can be
observed between uninfected and infected cells (Figure 3.11 C-F). Figure 3.11A and Figure
3.11B depict the collagen matrix alone, while uninfected cells (Figure 3.11 C, D) and infected
cells (Figure 3.11 E, F) were captured under different magnifications (2000-9000X).

Figure 3.11 Cryo-SEM images of 3D Vero cells exposed to crude Stx preparation of MitoC
induced STEC 204P O157:H7 incubated for 8 h.
(A and B) Collagen matrix; (B and C) Uninfected Vero cell embedded in collagen matrix; (E and
F) depicts the damage of Vero cells after a 8 h exposure to toxins from mitomycin C induced
STEC.

3.5

Discussion

The diversity in STEC serotypes and Stx subtypes makes it difficult to optimize and
develop detection platforms for food testing. The CARD system was developed to overcome this
issue and can screen different STEC serotypes and Stx subtypes because it mimics the natural
environment of STEC pathogenesis. Since viable STEC cells worked best as the analyte for 3DCARD in food testing using Vero cells as described in the previous chapter, we investigated
whether CARD would have a similar or better performance using THP-1 cells against the toxin
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preparations. Interestingly, 2D-THP-1 cells generated lower cytotoxicity values compared to 2DVero cells after exposure to viable STEC 204P O157:H7 and EDL933 cells for 16 h. This may
be due to bactericidal activity from activated THP-1 monocytes in response to LPS of STEC, and
lack of Stx expression during STEC survival and replication in THP-1 cells (Etienne-Mesmin et
al. 2011). When exposed to commercial Stx1a, Stx2a, and Stx2c preparations for 16 h, 2D
undifferentiated THP-1 cells responded better than 2D Vero cells and 3D undifferentiated THP-1
cells, but generated significantly lower cytotoxicity values compared to 3D Vero cells (Figure
3.2). The level of Gb3 or Gb4 receptors, rate of Stx internalization and the time it takes to induce
apoptosis and cell death are potential explanations for the differences observed. This finding
prompts us to compare Stx sensitivity from two different cell lines under 2D and 3D
configurations.

This is also the first study detailing a Stx screening scheme using lactate

dehydrogenase as a biomarker for cytotoxicity in undifferentiated THP-1 cells.
Highly purified Stx was obtained from BEI Resources and Toxin Technologies to serve
as our positive control. It was also used to determine the sensitivity of the assay or LOD, which
was found to be 31.25 ng/ml for 2D THP-1 cells, 62.5 ng/ml for 3D THP-1 cells, 500 ng/ml for
3D Vero, and 1000 ng/ml for 2D Vero at 16 h. The difference in the level of sensitivity may be
due to apoptotic death rate of cell lines, level of Gb3 or Gb4 expression regulated by cell cycle,
and/or slower diffusion of toxin molecules (Majoul et al. 2002; Lee et al. 2005; Banerjee et al.
2008; Banerjee and Bhunia 2009; Bouzari et al. 2009). Purification procedure for Stx can be
tedious and cumbersome. In order to assess virulence potential of different strains of STEC, cellfree crude Stx was prepared. Among the phage induction treatments used, addition of mitomycin
C was determined to be the best treatment for Stx2 induction. As shown, culture filtrates must be
concentrated in order to visualize and confirm the presence of Stx release using dot blot analysis.
Similar levels of Stx1 and Stx2 yield was achieved as described in published papers using
ciprofloxacin at 100 ng/ml and mitomycin C at 2 μg/ml (McGannon et al. 2010). Authors that
have performed UV induction and polymyxin B treatment for Stx production lacked the
information of quantifying Stx protein after treatment, which makes it difficult to compare our
data with current literature (Yokoyama et al. 2000; Aertsen et al. 2005a; Rocha and Piazza 2007).
Although ciprofloxacin treatment induced high levels of Stx1, production and release of Stx2
was much lower than mitomycin C treatment. Since Stx2 is frequently associated with HUS and
has been reported to be more potent than Stx1 (Alperi and Figueras 2010), mitomycin C was
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selected as a suitable antibiotic for STEC enrichment to ensure Stx2 production. Much attention
has been given to Stx2 rather than Stx1 in detection platforms that were recently developed
(Zhang et al. 2008; Quiñones et al. 2009; He et al. 2011; Quiñones and Swimley 2011; He et al.
2013a).
Cytotoxicity data correlates with dot blot analysis, showing a strong positive signal only
from samples containing high Stx yield (Figure 3.6, Figure 3.7, Table 3.4). Vero cells treated
with culture filtrate from MitoC or UV induced STEC strain 204P achieved cytotoxicity values
that were significantly higher than treatments with culture filtrate from Cipro or PolyB induced
STEC. This has been validated with 2D Vero, 3D Vero, and 2D undifferentiated THP-1 cells
with similar trends in its response to Stx. Furthermore, culture filtrates must be concentrated in
order to achieve a strong positive signal. Trypan blue staining of mammalian cells and CryoSEM images of infected 3D Vero cells were in agreement with cytotoxicity data. Mammalian
cells were stained blue after exposure to crude Stx preparations, but no Trypan blue uptake was
observed in culture filtrates of non-pathogenic E. coli. This suggests that Stx may be the cause of
Vero and THP-1 cell death and membrane damage. Structural difference in uninfected and
infected Vero cells was noticeable after performing Cryo-SEM, indicating Stx associated damage.
Optimal time of detection was determined to be 6 h after establishing the 12% cutoff value by
taking 3 standard deviations above the mean of all negative controls as described in published
literature (Zhang et al. 1999; Moodie et al. 2010). At 16 h, a similar trend was observed for crude
and commercial Stx with 3D Vero cells inducing the highest cytotoxicity response when
compared to 2D Vero, 2D THP-1, and 3D THP-1 cells. At 6 h however, no significant difference
was observed among cell lines and 3D vs 2D cells. After evaluating the limit of detection at 6 h,
slight changes was observed with 3D Vero exhibiting similar level of sensitivity to 2D THP-1
and can detect toxin up to 31.25 ng/ml. Diffusion of toxin molecules within the collagen matrix
or development of resistance to low dosage of Stx in a 3D condition may be responsible for the
differences observed with 3D Vero cell line. However, no reference literature is available to
compare and validate the data.
Despite the similar cytotoxicity profile of both cell lines against crude Stx preparation
after 6 h, 3D Vero cells remains to be a competitive model for CARD. Overall, 3D Vero cells
performed the best in response to STEC cells (discussed in Chapter 2), and can detect
functionally active crude Stx as low as 31.25 ng/ml in 6 h.

89

CHAPTER 4.

CONCLUSION AND FUTURE DIRECTIONS

4.1

Conclusions

Here, we demonstrated that the Vero-cell based assay, CARD, could be used for rapid
detection of STEC by measuring lactate dehydrogenase release. Among the different media
(Mtsb, DMEM, LB, EC), antibiotic treatment (MitoC, Cipro, and PolyB) and cell culture
platforms (2D versus 3D configuration) tested, uninduced STEC resuspended in LB exhibited
reasonable cytotoxicity levels (26% - 81%) that is above the 15% threshold after 6 h post
infection with a 3D Vero cell configuration. Concentrated culture filtrates after mitomycin C
induction also induced comparable levels of cytotoxicity, which was validated with dot blotting
showing high Stx2 yield (3.2 fold). Despite the high Stx1 production from ciprofloxacin
induction (1.4 fold), low Stx2 yield was achieved. Mitomycin C was chosen for further studies
due to the level of importance of Stx2 in STEC infection and its association with HUS. When
compared to control cells, mammalian cell morphology was profoundly different in response to
viable STEC cells and active Stx after Trypan blue staining and cryo-SEM. Vero cells in either
2D and 3D configuration can detect up to 107-8 CFU/ml or 1000 ng/ml and 31.25 ng/ml of Stx in
6 h, respectively. THP-1 cells did not exhibit a strong positive signal against STEC cells as
compared to Vero cells, but can detect up to 125 ng/ml of Stx and 31.25 ng/ml of Stx in a 2D and
3D configuration, respectively. Since 3D Vero cells performed the best in response to both STEC
cells and crude Stx, 3D Vero cells was chosen to develop CARD. 3D-CARD was successfully
used for the screening and detection of artificially contaminated samples from ground beef in 6 h,
which is faster than the 72 h traditional gold standard Vero cell assay. This method also
established an opportunity to screen for emerging STEC serotypes with similar cytotoxicity
potential. Therefore, this method for screening viable STEC has the potential to be adapted in the
food industry and public health sector for the screening of STEC from various samples to
prevent future occurrence of STEC related foodborne outbreaks.

4.2

Recommendations for Future Research

A limitation with 3D-CARD is its low sensitivity in detecting viable STEC cells (~107-8
CFU/ml) with the need of a 15 h enrichment step. We propose to improve the sensitivity and
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detection time of the assay by relying on the interaction between toxin/pathogen and mammalian
cell to probe for calcium release or early apoptosis. Recent studies have explored the effect of
Stx on cell signal transduction and immune modulation (Johannes and Römer 2010; MeltonCelsa 2014). The 1980 study using rabbits as the animal model showed evidence of Stx induced
apoptosis, which has led major efforts in elucidating its molecular mechanism. Stx-mediated
damage may induce a ribotoxic stress response, which can be pro-inflammatory and proapoptotic. Apoptosis can be induced through different mechanisms and is dependent upon the
type cell line used. For instance, a THP-1 cell activates ER stress response following protein
inhibition in the ER after Stx exposure. Simultaneously, ER stress can lead to Ca2+ release and
activates Ca2+-dependent cysteine protease calpain, which cleaves and activates caspase 8. This
may either activate caspase 3 or induce apoptosis by cleaving BID. In HeLa cells, Stx apoptotic
signaling pathway requires activation of caspase 8, caspase 6, and caspase 3. In human brain
microvascular endothelial cells (HBMEC), Stx induced apoptosis requires DNA fragmentation
and activation of caspase 3, caspase 6, caspase 8, and caspase 9. Mechanism of Stx mediated
apoptosis has not been elucidated for Vero cells other than confirmation of apoptosis induction
through DNA fragmentation, Hoechst staining, and western blotting (Inward et al. 1995; Bouzari
et al. 2009; Li et al. 2009).
Since apoptosis can be detected in 2 to 6 hours using DNA fragmentation and flow
cytometry as described in published literature (Kojio et al. 2000; Ching et al. 2002; Fujii et al.
2003; Burlaka et al. 2013; Kurohane et al. 2014), we can potentially use apoptotic assays to
improve sensitivity and detection time of the assay. More importantly, we would need a feasible
and convenient method that could be used in a food testing facility. Flow cytometry detecting
apoptosis using Annexin V conjugates could be a possible method, however, this method may
not be suitable to certain cell lines (Figure A.1-A.3). Interestingly, non-specific binding was
found in untreated Vero cells when we first attempted to validate the use of flow cytometry to
detect early apoptosis in Stx treated Vero cells. The data contradicts with published literature,
however, similar concerns were addressed by BD Biosciences-Pharmingen as technical
documents have shown unresolved issues using adherent cells line such as HeLa and HEK 293
cells. A suspension cell line such as undifferentiated THP-1 cell line may be better suited for this
method since similar issues were not addressed by BD Biosciences-Pharmingen with successful
results as indicated by authors. We then tried DNA fragmentation, a traditional assay that detects
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apoptosis, on both Vero and THP-1 cells (Figure. B1-B3). Cells were exposed to Camptothecin
(1 µM), heat treatment at 44ºC, and hydrogen peroxide (0.1 mM), which were typical apoptotic
inducers as a positive control to optimize the assay. With multiple attempts in extracting DNA
with our own buffers, we were able to detect the smallest fragment of DNA extracted, but no
laddering effect was observed. This may be a reason why most authors used a DNA laddering kit
that rapidly extracts and concentrate chromosomal DNA for high recovery of fragments.
Nonetheless, no conclusions can be drawn with early trials of using flow cytometry and DNA
fragmentation to detect apoptosis.
Although flow cytometry and DNA fragmentation visualized by agar gel electrophoresis
are possible ways to detect apoptosis, there may be alternative methods that are rapid and
convenient for food application potential. Caspase activation assays targeting caspase 3, caspase
6, and/or caspase 8 activity and calcium release assays using Fluo-4, 0-cresolphthalein, or Fura-2
may be used with 3D-CARD in a 48 well plate format, allowing multiple sample testing and
reduce cost. Monitoring early events of apoptosis before triggering cell death could potentially
reduce the 6 h detection time of 3D-CARD. Authors could detect as low as 1 ng/ml of Stx1 in 4
h using flow cytometry and DNA fragmentation or 10 ng/ml of Stx1 in 3 h using caspase activity
assays on HeLa and Vero cell lines (Fujii et al. 2003). About 10 ng/ml of Stx2 can be detected in
2 to 6 h from HBMEC cells using DNA fragmentation and western blotting (Fujii et al. 2008).
Calcium release assay using Fluo-5F was able to detect 400 ng/ml of Stx1 in 1 h from THP-1
cells (Lee et al. 2008; Cherla et al. 2009). Ca2+ indicator dye FM5f-AM was also used to detect
Stx2 (3.45 μM) in 20 min from hippocampal neuronal cultures using confocal microscopy
(Obata et al. 2015).
Improvement of 3D-CARD will have both basic and applied impact. This study will be
vital in understanding the cellular events involved in apoptosis in response to Stx. Additionally,
this detection platform has potential to be delivered as a hand-held portable device for field
deployment to aid in biodefense, threat reduction, and food safety. The model proposed will be
able to provide faster results, while improving the sensitivity to detect active Stx or viable STEC.
Approaches of the proposed research may be well suited to screen these contaminants in the food
supply rapidly as compared to lengthy and expensive traditional culturing methods. Finally, this
project has the potential to yield a diagnostic tool to help confirm patient’s illness to prescribe
appropriate medication for faster recovery.
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APPENDIX A. FLOW CYTOMETRY ANALYSIS OF APOPTOSIS USING
VERO CELLS

Introduction
While running LDH cytotoxicity assays, we attempted to differentiate apoptotic cells from dead
cells.

Methods
Cell culture and growth conditions
African green monkey kidney (Vero) cells were purchased from the American Type Culture
Collections (ATCC, Manassas, VA) and maintained in Dulbecco’s modified Eagles medium
(DMEM, Sigma, St. Louis, MO, USA) with 10% fetal bovine serum, respectively. Vero cells
(3.2 x 104 cells) were grown as monolayers in 48 well plates at 37°C with 7% CO2 under
humidity for 24 h. Cell monolayers were trypsinized with 0.25% of trypsin (Sigma) as described
in ATCC protocol and cell counts were determined by Trypan blue (0.4%) staining (Sigma).

Apoptosis of Vero cells
Vero cells (ATCC, Manassas, VA, USA) were washed with DMEM before exposure to
commercial Stx1 or Stx2 toxin (1 mg; Toxin Technologies, Sarasota, FL). These cells were
incubated at 37 °C for 12-16 h in a 5% CO2 atmosphere and tested for apoptosis by Annexin VPE staining (Annexin PE Apoptosis detection kit, BD Pharmingen, San Diego, CA). Briefly,
Vero cells were detached with trypsin (0.25%), EDTA (10 mM in PBS), or accutase cell
detachment solution (BD Biosciences, San Jose, CA) for 3 min. Cells were then washed with
cold PBS twice before centrifugation at 0.8 rcf for 3 min at 4°C and re-suspended at 1 × 106
cells/ml in 1 ml of binding buffer. Cells (100 μl aliquot, ~105 cells) were stained with 5 μl of
Annexin V-PE and 5 μl of 7-Amino-actinomycin (7-AAD, incubated for 15 min in the dark at
room temperature, and mixed with 400 μl of 1X binding buffer. Samples were analyzed on the
BD Accuri Flow Cytometer (BD Biosciences, San Jose, CA, USA) within 1 h. Approximately
10,000-30,000 events were collected from each sample analyzed and the percentage of early
apoptotic, late apoptotic/necrotic and viable populations were calculated using heat treatment at
60°C for 5 min as positive control and no heat treatment as negative control.
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Evaluation of non-specific binding
Untreated Vero cells were prepared as described above for testing apoptosis with slight
modifications. After re-suspension in 1 ml of binding buffer, 100 μl aliquot of cells were stained
with different volumes (1-5 μl) of Annexin V-PE or 7 AAD, incubated for 15 min in the dark at
room temperature, and reaction was stopped with 400 μl of binding buffer. Samples were
analyzed on the BD Accuri flow cytometer within 1 h.

Results and Discussion
We attempted to use flow cytometry to detect apoptosis in Vero cells after treatment with
commercial Stx (Figure A1). Heat treated Vero cells induced 16.8% cell death and 80.2%
apoptosis while untreated Vero cells showed 0.79% cell death and 54% apoptosis. Stx1 treated
cells and Stx2 treated cells at 12 and 16 h had comparable levels of cell death and apoptosis.
After 12 h, 63.6% and 58.9% of Vero cells treated with 1 mg of Stx1 and Stx2, respectively,
became apoptotic. After 16 h, 53% and 42% of Vero cells became apoptotic after exposure to 1
mg of Stx1 and Stx2, respectively. It was expected to see cell death and apoptosis after heat or
Stx treatment, but this should not be the case for untreated Vero cells. Untreated Vero cells were
visualized under the microscope before testing for apoptosis and no signs of structural change in
cellular morphology or trypan blue uptake were observed. This led us to investigate the nonspecific binding of both PE Annexin V and 7AAD dyes (Figure A2, Figure A3). The peak
shifted from 38% to 99% with increasing volumes of PE Annexin V added to untreated Vero
cells. On the other hand, no shift in peak was observed in untreated Vero cells with increasing
volumes of 7AAD. When cells undergo apoptosis, membrane phospholipid phosphatidylserine
(PS) gets translocated from the inner leaflet to the outer leaflet of the plasma membrane.
Annexin V can bind to PS since it is a calcium dependent phospholipid binding protein and can
probe for apoptosis if Annexin V is conjugated to fluorochromes such as Phycoerythrin (PE).
Cells that no longer have an intact membrane are permeable to dyes such as 7AAD and would be
an indicator for cell death. Interestingly, BD Pharmingen also had similar issues with attachment
cells such as HEK 293 and HeLa cells, resulting in Annexin V+ 7-AAD- and Annexin V- 7-AADcells. Issues, however, remained unsolved (personal communication with Andrew Jackson, BD
Bioscience). Cell lines must be verified before performing apoptosis assay. THP-1 cells, for
example, may be better suited for this method as authors have used this cell line with flow

110
cytometry in understanding apoptotic mechanism involved in STEC pathogenesis and Stx mode
of action (Lee et al. 2007; Babu et al. 2008b; Fujii et al. 2008; Lee et al. 2008).

Figure A.1 Representative histograms depicting apoptosis of Vero cells. Vero cells were exposed
to 1 mg of Stx1 or Stx2 for 12-16 h before testing for apoptosis.
Untreated cells were 7-AAD negative, but were PE Annexin V positive indicating that they were
viable, but undergoing apoptosis. Heat-treated cells were 7AAD and PE Annexin V positive,
indicating that they are undergoing apoptosis and cell death. Similar trends were seen when
comparing heat-treated cells with Stx treated cells.
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Figure A.2 Representative histograms showing untreated Vero cells after staining with PE
Annexin V.
Untreated Vero cells were prepared with different volumes (1-5 μl) of PE Annexin V before
testing for apoptosis. Unstained cells are depicted in the top panel. Gradual increase of PE
Annexin V positive cells was observed at increasing volumes of PE Annexin V used, indicating
that there may be non-specific binding.
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Figure A.3 Representative histograms showing untreated Vero cells after staining with 7AAD.
Untreated Vero cells were prepared with different volumes (1-5 μl) of 7AAD before testing for
cell death. Unstained cells are depicted in the top panel. Untreated cells were negative for 7AAD
regardless of volume of 7AAD used, indicating there may be specific binding.
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APPENDIX B: DNA FRAGMENTATION ANALYSIS OF APOPTOSIS
USING VERO AND THP-1 CELLS

Introduction
DNA fragmentation was evaluated as a potential indicator of early apoptosis as an alternative
approach compared to flow cytometry and PE Annexin V staining.

Materials and Methods
Vero and THP-1 cells were grown in DMEM or RPMI, respectively with 10% heat inactivated
fetal bovine serum (FBS) in a 5% CO2 incubator at 37°C. Mammalian cells were seeded in 48
well plates at a concentration of 3.2 × 104-6 cells in 0.5 ml of DMEM or RPMI with 10% FBS
per well and with either campthothecin (1-5 μM) for 0.5 to 5 h, heat treatment at 44°C for 5-60
min or hydrogen peroxide (0.1 mM). After a 4-h incubation, DNA was extracted as described by
Suman and colleagues (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261451/). Briefly, cells
were detached, washed with PBS, and pelleted before the addition of DMSO (100 μl). TE buffer
(pH 7.4, 100 μl) and 2% SDS (100 μl) was added to the mixture and centrifuged at 12,000 x g at
4 °C. 40 μl of the supernatant was loaded on 2% agarose gel and electrophoresis was performed
at 70V for 1 to 2 h.

Results and Discussion
We attempted to optimize DNA fragmentation assay using camptothecin, heat treatment, and
hydrogen peroxide as positive controls. Apoptotic controls were used at recommended levels and
duration as published in the literature (loannou and Chen 1996; Bhunia and Feng 1999; Solier et
al. 2009; Xiang et al. 2016). Low molecular weight DNA fragments were visualized with the loss
of high molecular weight fragments regardless of treatment. Low recovery of apoptotic DNA
maybe due to sample preparation using buffers made in house. DNA yield can be improved
using commercial DNA laddering kits to concentrate and recover all DNA fragments to visualize
the laddering effect after running gel electrophoresis.
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Figure B.1 Effect of Camptothecin on DNA fragmentation in undifferentiated THP-1 cells over
time.
THP-1 cells (3.2 × 104) treated with camptothecin (1 μM) for 30 m to 5 h showed no laddering
except for low molecular weight fragments (~200 bp).
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Figure B.2 Effect of Camptothecin at increasing concentrations and heat treatment at over time
on DNA fragmentation in undifferentiated THP-1 cells.
THP-1 cells (3.2 × 104) treated with camptothecin (0.01-5 μM) for 2 h showed undetectable
amounts of laddering. Untreated cells were used as a negative control showing no DNA
laddering. Heat-treated cells at 44°C for 1 to 60 min showed no laddering except for low
molecular weight fragments (~200 bp).
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Figure B.3 Effect of heat, Camptothecin, and hydrogen peroxide at on DNA fragmentation in
undifferentiated THP-1 cells and Vero cells.
(A) THP-1 cells or (B) Vero cells (3.2 × 106) treated at 44°C for 5 min showed no or low levels
of laddering except for low molecular weight fragments (~180-600 bp). Camptothecin (1 μM)
treated THP-1 and Vero cells for 2 h also showed undetectable amounts or low levels of
laddering (~180-600 bp). Untreated cells were used as a negative control and showed no DNA
laddering. Cells treated with hydrogen peroxide for 30 min showed no laddering except for low
molecular weight fragments (~180-600 bp).

117

APPENDIX C: REACTIVITY OF STX1-2 AND STX2-5 MAB AGAINST
COMMERCIAL STX

Introduction
Western blot was used to confirm Stx specificity of anti-Stx mAbs donated by Dr. Xiaohua He
(USDA Western Region Center, Emeryville, CA).

Materials and Methods
For SDS-PAGE, Commercial Stx1 or Stx2 (2 μg; Toxin Technologies, Sarasota, FL) were boiled
with sample solvent (2 μl) at 100°C for 5 min before centrifugation (8000 x g) for 1 min. 15%
polyacrylamide gels were equilibrated in running chamber with 1X running buffer at 100V for
20 min. Samples and protein ladder (8 μl, Bio-rad, Hercules, CA) were loaded into wells and
electrophoresis was performed at 100 V for 1.5 h or until loading dye has reached the bottom of
the gel. Gels were placed in transfer buffer for 10 min while PVDF membrane (pore size of 0.2
μm) was soaked in methanol for 2 min and then soaked in transfer buffer for 2 min before
preparing the stack. Gels were transferred to the membrane at 50V for 45 min before blocking in
5% non-fat dry milk in TBST at room temperature for 45 min. Membranes were washed with
TBST three times at room temperature for 3 min before overnight incubation with Stx1-2 or
Stx2-5 mAb at 4°C. Membranes were then washed 3 times with TBST at room temperature for 3
min and incubated with anti-mouse secondary antibody conjugated with horse radish peroxide
(HRP) at room temperature for 2 h. Membranes were washed again for 3 times (3 min each) and
developed with SignalFire (3:2 dilution in purified water) at room temperature in the dark for 30
sec. Blots were visualized using XRS+ Chemidoc Imaging System (Bio-rad, Hercules, CA).
Results and Discussion
Stx 1-2 mAb can specifically detect Stx1 (Figure C.1). No cross reactivity was observed with
Stx2 and supernatant from Stx negative strain 489. A faint band was seen with Stx 2-5 mAb
reactivity against Stx2 protein, indicating potential specificity of mAb to Stx2 (Figure C.1). This
was not observed in culture filtrates from Stx- negative strain 489 or Stx1. As expected, Stx2-5
mAb does not work well with Stx2 under denatured conditions as the antibody was designed for
ELISA screening of the native protein. This has been confirmed through personal
communication with Dr. Xiaohua He. Stx1-2 works well with denatured Stx1 protein and has
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been documented to detect Stx1 native protein. We attempted to perform Native PAGE to further
confirm Stx2-5 specificity to Stx2. However, no detectable bands were seen. This may be due to
50% purity of commercial Stx protein purchased from Toxin Technologies since Stx2 was noted
to be visible on western blot if concentrated by 10 fold.

Figure C.1 Stx1-2 and Stx2-5 mAb reactivity profile to commercial Stx1 and Stx2
Commercial Stx1 and Stx2 (2 μg) were added to each well before incubation with Stx1-2 or
Stx2-5 (1:1000) to assess specificity of the mAbs. Blots were visualized using HRP linked
secondary antibody and SignalFire chemiluminescence substrate.
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APPENDIX D: OPTIMIZATION OF INDIRECT ELISA USING STX1-2
AND STX2-5 MABS

Introduction
We attempted to use ELISA to quantify Stx using anti-Stx mAbs donated by Dr. Xiaohua He
(USDA Western Region Center, Emeryville, CA).

Materials and Methods
Commercial Stx1 and Stx2 (Toxin Technologies, Sarasota, FL) were diluted to a final
concentration of 1 to 1000 ng/ml using carbonate/bicarbonate buffer (pH 7.4). 100 μl of purified
Stx was dispensed into wells of 96 well plates (Immulon HBX, Thermo Scientific, Rochester,
NY). Plates were sealed and incubated overnight at 4°C. Then, plates were washed three times
with Tris buffered saline and 0.1% Tween (TBST) before blocking with 200 μl of TBST with 5%
non-fat dry milk for 1 h. Plates were washed again three times with TBST before overnight
incubation with 100 μl of Stx1-2 or Stx2-5 primary antibody (1:1000 dilution) at 4°C. Plates
were washed three times with TBST and then incubated with 100 μl of anti-mouse secondary
antibody conjugated with HRP (1:2000) for 2 h at room temperature. After washing the plate
three times with TBST, 200 μl of o-phenylenediamine dihydrochloride (SIGMAFAST OPD,
Sigma) substrate solution was added to each well and incubated in the dark at room temperature
for 30 min. Reaction was stopped with 50 μl of 3 N HCl and read at 490 nm using a UV
spectrophotometer.

Results and Discussion
In the Stx1 standard curve (Figure D1A), the absorbance decreases dramatically at higher
concentrations. This may be due to non-specific binding of the protein to itself or issues with
coating the antigen to the 96 well plates before incubation with Stx1-2. mAb. However, this
trend was not observed in the Stx2 curve since absorbance increases at higher concentrations.
When ELISA was performed against crude Stx preparation from STEC 204P and E. coli 489
(Table D1), non-specific binding was observed. Contamination of wells could be a possible
reason, however, three independent experiments showed similar results. This was not the case
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when dot blot was performed, which has led us to pursue using dot blot to quantify crude Stx
protein.

Figure D.1 ELISA standard curves for commercial (A) Stx1 and (B) Stx 2 protein.
Two fold dilutions of commercial Stx (1-1200 ng/ml) were allowed to bind to Stx1-2 or Stx2-5
mAbs by indirect ELISA and visualized with HRP linked anti-mouse secondary antibody and
SIGMAFAST OPD at 490 nm.

Table D.1 Absorbance values from crude Stx preparation after MitC (2 μg/ml) treatment
E. coli isolate
489 O157:H12
204P O157:H7

Stx1

Stx2
Absorbance (490 nm)
0.32±0.16
0.24±0.048
0.67±0.10
0.34±0.049
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